Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
40758310	s-he4	pmol/l (pmol/l)	7681	10779	0.00%
40758310	p-he4	pmol/l (pmol/l)	1558	2092	0.14%
40758310	s-he4	— (—)	362	404	100.00%	Distribution not available
40758310	he4proteiini	pmol/l (pmol/l)	10	10	0.00%	Distribution not available
40758310	s-he4ihmisenepididymaalinenproteiini4	pmol/l (pmol/l)	7	7	0.00%	Distribution not available
40758310	p-he4	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Solid cancers, helper endpoint

2002

4408

2.75

322.23

1.5

1.4

207.63

59.93

pmol/l

21.14

1960

4306

Malignant neoplasm

1999

4428

2.74

319.48

1.5

1.4

206.99

59.84

pmol/l

20.99

1959

4325

Any event in cancer register

2260

5050

2.70

307.65

1.5

1.4

181.97

64.15

pmol/l

17.74

2210

4926

Noninflammatory disorders of female genital tract

1211

1489

4.24

307.65

1.5

1.4

113.55

238.16

pmol/l

5.33

1176

1438

Other symptoms and signs involving the digestive system and abdomen

1131

1477

8.71

307.65

1.6

1.3

161.96

109.37

pmol/l

2.87

1103

1445

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

401

198

33.47

307.65

1.7

1.4

820.18

64.30

pmol/l

21.30

389

191

Endometriosis of pelvic peritoneum

747

1017

7.62

307.65

1.5

1.4

83.94

207.96

pmol/l

5.84

729

988

Endometriosis ASRM stages 3,4

1224

3254

4.12

307.65

1.6

1.4

61.05

148.64

pmol/l

13.38

1196

3167

Malignant neoplasm of ovary, including Hilmo

1012

533

31.01

307.65

1.8

1.4

457.66

65.81

pmol/l

27.88

974

518

malignant neoplasm of female genital organs

1609

1297

16.13

307.65

1.6

1.4

394.17

75.72

pmol/l

30.38

1565

1270

Ovarian cyst

3064

1449

14.18

307.65

1.5

1.4

72.84

242.46

pmol/l

12.27

2991

1404

Unspecified/other endometriosis

466

506

10.16

307.65

1.5

1.4

67.34

185.63

pmol/l

3.74

446

491

Endometriosis

1578

1423

6.99

307.65

1.6

1.4

79.49

245.51

pmol/l

10.64

1533

1380

Malignant neoplasm, wide definition for exclusion

2097

4582

2.75

307.65

1.5

1.4

194.96

59.22

pmol/l

20.20

2057

4475

Exclusions for E4_PCOS_CONSORTIUM

2718

5274

3.38

307.65

1.5

1.4

154.20

91.95

pmol/l

6.30

2656

5129

Malignant neoplasm of corpus uteri, including Hilmo

740

694

13.04

307.65

1.3

1.4

190.91

73.79

pmol/l

5.71

730

675

Neoplasms

1657

2273

3.95

307.65

1.6

1.3

119.31

51.12

pmol/l

5.97

1622

2183

Any gastric operation

1829

2803

3.35

307.65

1.5

1.3

145.84

58.90

pmol/l

8.89

1780

2730

Benign neoplasm of ovary

955

2209

4.81

307.65

1.4

1.5

70.71

187.43

pmol/l

13.54

949

2148

Ascites

396

374

11.97

307.65

1.7

1.4

698.26

139.33

pmol/l

12.91

377

368

Serous carcinoma of ovary, including Hilmo

511

262

32.53

307.65

2.0

1.4

625.52

69.44

pmol/l

19.30

488

254

GASTRO-related operations

1829

2803

3.35

307.65

1.5

1.3

145.84

58.90

pmol/l

8.89

1780

2730

Malignant neoplasm of corpus uteri

635

574

13.56

307.65

1.4

201.37

73.43

pmol/l

5.17

628

560

Endometriosis of ovary

1096

1115

10.90

307.65

1.6

1.4

55.77

240.53

pmol/l

12.69

1070

1079

Malignant neoplasm of ovary

735

380

31.63

307.65

1.8

1.4

496.01

69.38

pmol/l

19.82

704

368

Polyp of the female genital tract

945

1291

4.40

296.52

1.4

113.50

266.54

pmol/l

7.45

927

1251

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

495

827

6.31

284.32

1.7

1.4

548.02

69.57

pmol/l

12.16

483

801

Female infertility, cervical, vaginal, other or unspecified origin

826

1251

4.48

279.16

1.4

95.81

213.00

pmol/l

5.10

806

1218

Female infertility

876

1279

4.33

276.98

1.4

97.84

211.41

pmol/l

5.07

853

1242

Postmenopausal bleeding

862

1084

4.47

265.60

1.4

131.54

298.26

pmol/l

6.80

847

1053

Congenital malformations of ovaries, fallopian tubes and broad ligaments

450

761

7.07

263.82

1.4

1.5

48.60

137.56

pmol/l

3.03

437

747

Congenital ovarian cysts

397

610

8.03

257.05

1.4

47.99

102.39

pmol/l

2.01

388

598

Excessive, frequent and irregular menstruation

970

1480

3.71

243.07

1.5

1.4

102.61

238.98

pmol/l

7.42

933

1431

Congenital malformations of genital organs

514

1070

5.29

233.89

1.4

1.5

55.35

116.88

pmol/l

2.66

498

1046

Pain and other conditions associated with female genital organs and menstrual cycle

569

1176

4.64

227.04

1.5

1.4

63.05

196.75

pmol/l

11.15

543

1137

Appendectomy

1611

6719

2.35

211.19

1.5

1.4

189.00

106.21

pmol/l

6.72

1574

6556

Menorrhagia

832

1360

3.50

193.88

1.5

1.4

115.48

255.96

pmol/l

6.48

811

1318

Benign neoplasms

1815

4671

2.17

176.62

1.5

1.4

100.78

138.67

pmol/l

2.54

1774

4528

Adenomyosis (Endometriosis of uterus)

409

888

4.86

175.96

1.6

1.4

78.55

285.53

pmol/l

9.05

397

858

Symptoms and signs involving the digestive system and abdomen

1706

3865

2.24

174.17

1.5

1.4

158.14

98.72

pmol/l

3.79

1655

3779

Endometriosis ASRM stages 1,2

768

2668

3.07

166.22

1.5

1.4

83.17

121.86

pmol/l

1.44

746

2602

Other medical care

964

3351

2.65

162.24

1.6

1.4

397.37

118.29

pmol/l

13.64

930

3279

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

435

1076

4.12

153.81

1.5

1.4

284.57

69.19

pmol/l

5.99

426

1048

Hernia of abdominal wall, postoperative

341

715

4.91

151.81

1.5

1.3

205.91

72.77

pmol/l

3.48

335

698

Endometriosis diagnosis and infertility diagnosis occurring together

520

1556

3.63

145.76

1.5

85.61

114.22

pmol/l

0.60

509

1524

Genitourinary diseases

595

818

3.69

145.62

1.5

1.4

150.29

194.10

pmol/l

0.61

581

791

Abdominal and pelvic pain

1596

3865

2.10

139.51

1.5

1.4

139.94

98.72

pmol/l

1.87

1549

3779

Complications of procedures, not elsewhere classified

1639

6991

1.97

135.09

1.5

1.4

113.17

129.86

pmol/l

1.05

1595

6823

Complications of surgical and medical care, not elsewhere classified

1918

7119

1.87

130.59

1.5

1.4

127.01

128.45

pmol/l

0.05

1869

6944

Deep endometriosis

424

1211

3.80

127.55

1.6

1.4

64.43

164.09

pmol/l

5.75

417

1176

Other noninflammatory disorders of uterus, except cervix

512

1031

3.47

125.55

1.5

1.4

161.79

293.91

pmol/l

3.36

502

998

Leiomyoma of uterus

1862

5747

1.89

121.62

1.4

110.41

147.20

pmol/l

2.37

1822

5610

Endometroid carcinoma of ovary, including Hilmo

104

19.13

115.81

1.9

1.5

211.44

59.28

pmol/l

4.07

Other abnormal uterine and vaginal bleeding

487

1117

3.21

109.10

1.4

165.67

278.41

pmol/l

2.10

473

1077

Dysplasia of cervi uteri

485

1186

3.04

99.59

1.4

83.84

233.59

pmol/l

6.87

477

1150

Complications of medical and surgical care

1412

7129

1.85

97.80

1.5

1.4

119.41

134.33

pmol/l

0.78

1380

6959

Intestinal stricture

562

2180

2.64

96.40

1.7

1.4

251.38

172.39

pmol/l

2.33

546

2120

Salpingitis and oophoritis

613

2531

2.54

93.97

1.5

1.4

88.52

147.80

pmol/l

4.61

608

2472

Inflammatory diseases of female pelvic organs

1720

7521

1.72

87.91

1.5

1.4

100.04

130.57

pmol/l

1.65

1677

7327

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

249

637

4.02

86.08

1.7

1.4

235.99

64.47

pmol/l

6.18

244

618

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1129

6077

1.86

81.10

1.5

1.4

115.42

140.31

pmol/l

1.56

1106

5931

Oxycodone

665

2703

2.27

80.58

1.7

1.4

357.46

138.64

pmol/l

7.17

645

2640

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1046

5799

1.83

71.18

1.5

1.4

115.18

141.55

pmol/l

1.58

1024

5654

Paralytic ileus and intestinal obstruction

442

1840

2.45

65.31

1.7

1.4

238.47

175.18

pmol/l

1.46

428

1793

Other menopausal disorders

510

1217

2.41

63.45

1.3

1.4

113.15

264.84

pmol/l

4.51

501

1184

Abnormal findings on diagnostic imaging of other body structures

329

1255

2.72

59.17

1.4

119.19

168.53

pmol/l

1.65

318

1228

Hydronephrosis

231

739

3.23

57.13

1.7

1.4

309.60

164.59

pmol/l

2.07

226

724

Other or unspecified ileus, impaction or obstruction

307

1146

2.74

57.07

1.6

1.4

287.35

191.40

pmol/l

1.60

297

1115

Liquid cancers, helper endpoint

454

1757

2.28

56.31

1.6

1.3

194.57

71.21

pmol/l

8.35

446

1715

Congenital malformations, deformations and chromosomal abnormalities

1077

6159

1.69

55.07

1.4

78.11

112.61

pmol/l

3.99

1045

6002

Benign leiomyoma with endometriosis

453

2076

2.27

54.63

1.5

79.65

194.82

pmol/l

9.29

438

2020

Female genital prolapse

487

1235

2.27

53.29

1.5

1.4

136.28

276.58

pmol/l

3.86

477

1198

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1771

6398

1.52

52.95

1.4

140.52

122.29

pmol/l

0.90

1725

6238

Congenital malformations, deformations and chromosomal abnormalities

1162

6627

1.63

52.48

1.4

77.97

117.51

pmol/l

5.43

1126

6462

Nausea and vomiting

418

1833

2.27

52.13

1.5

1.4

197.16

111.71

pmol/l

3.49

406

1787

Malignant neoplasm of digestive organs

412

1428

2.30

51.30

1.4

146.48

75.81

pmol/l

2.60

405

1394

Procreative management

644

2818

1.94

51.08

1.5

1.4

118.32

115.74

pmol/l

0.05

630

2749

Follow-up examination after treatment for conditions other than malignant neoplasms

873

3293

1.78

50.68

1.4

87.53

129.56

pmol/l

3.97

854

3228

Persons encountering health services for specific procedures and health care

1754

7129

1.49

48.73

1.6

1.4

217.93

92.65

pmol/l

11.59

1700

6963

Anaemias

451

1376

2.18

46.58

1.6

1.4

146.87

45.36

pmol/l

3.37

442

1340

Malignant neoplasm of breast, including Hilmo

905

3533

1.69

43.08

1.4

141.94

62.17

pmol/l

7.06

882

3461

Malignant neoplasm of breast, HER2-negative, including Hilmo

904

3533

1.68

42.87

1.4

142.06

62.17

pmol/l

7.06

881

3461

Postmenopausal atrophic vaginitis

432

1116

2.17

42.62

1.4

121.38

295.44

pmol/l

6.78

420

1086

Malignant neoplasm of breast

884

3471

1.69

42.43

1.4

142.97

62.12

pmol/l

7.02

860

3399

Malignant neoplasm of breast, HER2-negative

864

3409

1.69

41.23

1.4

145.18

62.43

pmol/l

7.03

841

3339

Pain in joint

845

3226

1.69

40.75

1.4

118.79

138.45

pmol/l

0.47

822

3149

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

562

1466

1.94

40.58

1.5

1.4

164.27

81.29

pmol/l

1.66

548

1436

Other female pelvic inflammatory diseases

439

2233

2.03

40.17

1.5

1.4

87.79

155.15

pmol/l

3.86

424

2169

Other diseases of intestines

1675

6654

1.44

39.57

1.5

1.4

133.56

112.68

pmol/l

0.89

1628

6490

Medical treatment for female infertility

603

3399

1.81

39.16

1.4

53.52

76.47

pmol/l

2.70

590

3314

Malignant neoplasm of breast, ER-positive, including Hilmo

654

2904

1.77

38.19

1.4

118.25

64.54

pmol/l

4.93

638

2843

Any death

785

3393

1.67

37.68

1.5

1.4

491.33

120.76

pmol/l

14.91

756

3323

Malignant neoplasm of breast, HER-positive

639

2863

1.77

37.65

1.4

119.67

64.76

pmol/l

4.92

623

2802

Persons encountering health services in other circumstances, wide

1753

6406

1.42

37.14

1.5

1.4

137.61

122.36

pmol/l

0.73

1707

6246

Opioids

1594

5830

1.43

35.47

1.5

1.4

153.39

99.97

pmol/l

3.03

1544

5695

Irregular menses

1206

6483

1.49

35.24

1.4

85.24

112.40

pmol/l

1.56

1178

6316

Persons encountering health services in other circumstances

651

3888

1.69

33.86

1.6

1.4

146.11

127.00

pmol/l

0.32

630

3783

Parasetamol

1091

3646

1.53

33.56

1.5

1.4

131.11

101.31

pmol/l

0.86

1058

3553

Ventral hernia

385

1998

1.96

32.85

1.5

180.88

168.46

pmol/l

0.16

378

1940

Pleural effusion

187

727

2.62

32.30

1.6

1.5

458.94

193.79

pmol/l

3.19

177

707

Polycystic ovarian syndrome, consortium definition

1727

7487

1.38

32.00

1.4

117.60

126.55

pmol/l

0.31

1688

7288

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

903

5296

1.54

31.90

1.4

153.29

151.86

pmol/l

0.02

877

5165

Cystitis

1482

6316

1.41

30.82

1.4

119.97

117.97

pmol/l

0.06

1444

6160

Pain (limb, back, neck, head abdominally)

972

3223

1.52

29.43

1.5

1.4

138.44

138.13

pmol/l

0.01

945

3144

Fever of other and unknown origin

833

4872

1.53

29.14

1.5

1.4

183.04

124.94

pmol/l

1.72

814

4740

Disorders of the thyroid gland

1481

7061

1.37

27.56

1.5

1.4

120.05

121.04

pmol/l

0.02

1444

6875

Hernia of abdominal wall

568

3495

1.64

26.94

1.5

1.4

172.49

146.40

pmol/l

0.54

556

3395

Colectomy operation

238

1117

2.17

26.91

1.4

1.5

184.09

185.30

pmol/l

0.01

232

1088

Pulmonary heart disease

387

2156

1.82

26.44

1.6

1.5

332.86

178.55

pmol/l

2.04

381

2091

Pulmonary embolism

387

2160

1.81

26.29

1.6

1.5

332.86

178.28

pmol/l

2.05

381

2094

Intestinal adhesions without obstruction

149

580

2.64

25.95

2.0

1.4

174.25

193.50

pmol/l

0.20

144

567

DVT of lower extremities and pulmonary embolism

539

3295

1.65

25.82

1.5

1.4

308.34

160.16

pmol/l

2.86

526

3209

Other diseases of urinary system

1513

6316

1.35

25.06

1.4

130.61

117.97

pmol/l

0.38

1472

6160

Misadventures to patients during surgical and medical care

241

1182

2.08

24.40

1.5

109.91

166.99

pmol/l

1.77

234

1152

Other disorders of urethra and urinary system

1181

6167

1.39

24.24

1.4

151.88

119.75

pmol/l

0.83

1146

6015

Pulmonary heart disease, diseases of pulmonary circulation

400

2333

1.73

23.37

1.6

1.5

352.06

179.53

pmol/l

2.27

394

2264

Malignant neoplasm, without specification of site

5.67

22.83

1.6

1.4

451.07

69.08

pmol/l

0.78

Hypothyroidism, other/unspecified

1423

7024

1.34

22.73

1.5

1.4

115.01

121.45

pmol/l

0.27

1386

6841

Follow-up examination after treatment for malignant neoplasms

179

809

2.26

22.41

2.1

1.4

227.46

190.56

pmol/l

0.26

174

790

Hypothyreosis and Thyroxine purchase for inclusion criteria

1489

7404

1.33

22.22

1.5

1.4

127.18

124.74

pmol/l

0.07

1451

7216

Obesity due to excess calories

780

5379

1.46

22.14

1.4

127.18

113.71

pmol/l

0.42

749

5250

General symptoms and signs

1630

6229

1.32

22.07

1.5

1.4

129.81

116.52

pmol/l

0.65

1593

6071

Venous thromboembolism

697

4573

1.48

21.20

1.5

1.4

265.60

147.65

pmol/l

2.97

680

4450

Medicines for HER+ breast cancer

787

5217

1.45

20.79

1.6

1.4

140.39

159.46

pmol/l

0.65

766

5095

Hypothyroidism and >3 levothyroxin purchases

425

1434

1.69

20.64

1.6

1.4

84.53

45.13

pmol/l

3.50

408

1393

Hypothyroidism, levothyroxine purchases

425

1434

1.69

20.64

1.6

1.4

84.53

45.13

pmol/l

3.50

408

1393

Other nutritional deficiencies

1065

7389

1.37

20.37

1.4

123.79

118.64

pmol/l

0.16

1026

7215

Hypothyroidism (congenital or acquired)

424

1435

1.69

20.29

1.6

1.4

84.34

45.12

pmol/l

3.46

407

1394

Other functional intestinal disorders

650

4079

1.49

20.15

1.5

1.4

172.71

138.33

pmol/l

0.75

630

3982

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1464

7311

1.31

20.07

1.5

1.4

135.56

122.88

pmol/l

0.50

1415

7135

Agranulocytosis

194

961

2.06

19.29

1.7

1.5

273.73

176.49

pmol/l

0.99

189

943

Fentanyl

141

613

2.33

19.29

1.7

1.4

289.13

160.06

pmol/l

1.41

136

594

Malignant neoplasm of breast, ER-negative, including Hilmo

357

2041

1.69

18.89

1.5

1.4

216.22

69.87

pmol/l

4.37

348

1995

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1405

7475

1.30

18.67

1.5

1.4

171.79

120.03

pmol/l

2.80

1371

7289

Paracetamol or NSAID medication

190

450

2.14

18.30

1.4

122.95

103.80

pmol/l

0.13

185

435

Examination and observation for other reasons

807

3303

1.42

18.26

1.5

1.4

144.18

129.31

pmol/l

0.22

785

3238

Obesity and other hyperalimentation

1010

7275

1.35

17.72

1.4

126.52

118.76

pmol/l

0.24

975

7100

Obesity

1006

7255

1.35

17.68

1.4

126.86

118.76

pmol/l

0.25

971

7082

Diseases of peritoneum

161

769

2.14

17.67

1.5

177.42

192.99

pmol/l

0.12

156

754

First line medication for Crohn's disease

1585

6725

1.28

17.63

1.5

1.4

188.45

97.75

pmol/l

5.79

1541

6555

Malignant neoplasm of skin

478

2125

1.55

17.24

1.5

1.4

175.88

69.70

pmol/l

2.83

466

2077

Malignant neoplasm of breast, HER-negative

311

1814

1.71

17.22

1.5

1.4

205.21

70.62

pmol/l

3.82

303

1772

Medical observation and evaluation for suspected diseases and conditions

892

3304

1.39

17.20

1.6

1.4

134.64

129.35

pmol/l

0.10

867

3239

Headache

1037

6227

1.34

17.06

1.5

1.4

84.73

116.50

pmol/l

3.51

1007

6069

Dysphagia

263

1501

1.77

16.78

1.4

1.3

120.47

119.22

pmol/l

0.02

253

1470

Tramadol

1125

5250

1.32

16.52

1.5

1.4

175.60

106.35

pmol/l

3.03

1089

5138

Hypothyroidism, strict autoimmune

1202

6074

1.31

16.48

1.5

1.4

119.34

113.72

pmol/l

0.20

1170

5922

Any reimbursement code in KELA

950

3531

1.36

15.83

1.5

1.4

143.60

53.27

pmol/l

4.36

932

3440

Malignant melanoma, including Hilmo

160

796

2.03

15.67

1.4

82.73

66.72

pmol/l

1.20

155

774

Depression medications

442

1437

1.56

15.28

1.4

157.50

45.11

pmol/l

1.92

429

1396

Other pleural conditions

104

442

2.39

15.13

1.4

1.5

404.60

198.22

pmol/l

1.70

432

Constipation

1215

6555

1.29

15.05

1.4

163.45

134.04

pmol/l

0.84

1182

6410

Other diseases of blood and blood-forming organs, wide

301

1843

1.65

14.94

1.7

1.4

224.78

160.57

pmol/l

1.01

294

1797

Codeine

1351

5789

1.27

14.64

1.5

1.4

116.40

100.38

pmol/l

0.54

1305

5656

L02BA Anti-estrogens

364

2353

1.58

14.58

1.4

111.95

156.59

pmol/l

1.39

357

2295

Hypothyroidism, strict autoimmune, 3 medication purchases required

1375

7386

1.26

14.45

1.4

136.35

124.93

pmol/l

0.37

1337

7201

Cardiovascular diseases (excluding rheumatic etc)

1078

4781

1.30

14.14

1.5

1.4

141.08

80.46

pmol/l

2.77

1054

4660

Other disorders of the genitourinary system

239

1405

1.73

14.04

1.6

1.4

94.61

194.23

pmol/l

4.76

232

1373

All kidney diseases

1416

7763

1.25

13.82

1.5

1.4

192.44

110.44

pmol/l

6.66

1375

7569

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

436

1979

1.50

13.72

1.5

1.3

186.90

71.29

pmol/l

2.80

425

1934

Sequelae with surgical and medical care as external cause

267

1631

1.66

13.44

1.6

1.4

138.24

173.32

pmol/l

0.65

261

1588

Diverticular disease of intestine

868

4198

1.33

13.21

1.5

1.4

138.48

145.25

pmol/l

0.18

845

4110

Other malignant neoplasms of skin (=non-melanoma skin cancer)

400

1819

1.52

13.18

1.5

1.4

194.57

72.86

pmol/l

2.63

388

1778

Renal tubulo-interstitial diseases

1209

7145

1.27

13.17

1.5

1.4

215.42

113.49

pmol/l

7.66

1171

6966

Low back pain

1091

6144

1.28

13.04

1.4

105.12

125.88

pmol/l

0.94

1055

5986

Gastrointestinal diseases

913

3478

1.32

12.97

1.5

1.4

135.89

107.39

pmol/l

0.65

889

3389

Fenamates

229

905

1.74

12.91

1.4

166.24

126.46

pmol/l

0.35

221

875

Behavioural syndromes associated with physiological disturbances and physical factors

1359

7768

1.25

12.84

1.4

83.76

133.59

pmol/l

5.75

1319

7577

Pain in limb

1164

6172

1.27

12.64

1.4

126.95

124.67

pmol/l

0.04

1125

6020

Other diseases of pleura

392

2311

1.49

12.59

1.5

1.4

353.11

178.95

pmol/l

4.31

377

2247

Insomnia

1322

7773

1.24

12.44

1.4

82.23

131.48

pmol/l

5.53

1279

7584

Disorders of gallbladder, biliary tract and pancreas

1370

6982

1.24

12.41

1.5

1.4

121.47

134.02

pmol/l

0.59

1340

6814

All chronic kidney diseases

584

3464

1.39

12.31

1.7

1.4

279.82

140.58

pmol/l

6.53

562

3380

In situ neoplasms

556

4031

1.39

12.20

1.4

1.5

118.80

152.06

pmol/l

1.27

542

3924

Basal cell carcinoma

379

1751

1.51

12.18

1.5

1.4

198.57

73.55

pmol/l

2.51

367

1711

Sleep disorders

1322

7727

1.24

12.17

1.4

84.04

133.39

pmol/l

5.43

1280

7538

Sequelae of external causes of morbidity and mortality

322

2106

1.54

12.16

1.5

1.4

128.82

160.02

pmol/l

0.71

312

2046

Benzodiazepine use

1397

7841

1.23

11.84

1.4

174.68

117.47

pmol/l

2.08

1363

7643

Other soft tissue disorders, not elsewhere classified

1313

6218

1.24

11.82

1.4

128.12

124.11

pmol/l

0.08

1276

6064

Other diseases of intestine

167

931

1.81

11.76

1.4

209.47

176.75

pmol/l

0.27

160

910

Cholecystectomy

1043

7147

1.27

11.61

1.4

123.72

138.15

pmol/l

0.62

1020

6976

Inflammatory disease of uterus

305

2003

1.55

11.49

1.5

131.23

124.00

pmol/l

0.05

298

1954

Lower back pain or/and sciatica

1464

7868

1.22

11.26

1.4

113.59

127.71

pmol/l

0.45

1416

7677

Dermatitis and eczema

1511

7741

1.21

11.04

1.4

105.19

130.32

pmol/l

1.66

1468

7544

Basal cell carcinoma, including avohilmo

394

1865

1.46

11.03

1.5

1.4

195.15

72.28

pmol/l

2.58

380

1822

Unspecific neurodegenerative disorder

155

1853

0.57

10.94

1.4

1.5

226.20

245.13

pmol/l

0.11

148

1800

Septicaemia

421

2768

1.43

10.94

1.6

1.4

220.08

157.25

pmol/l

1.68

412

2698

Major coronary heart disease event excluding revascularizations

327

3214

0.67

10.89

1.5

1.4

195.80

176.69

pmol/l

0.22

322

3129

Malignant neoplasm of rectum, including Hilmo

411

2.18

10.75

1.5

1.4

202.84

71.25

pmol/l

0.96

396

Other septicaemia

375

2496

1.45

10.66

1.6

1.4

219.49

162.49

pmol/l

1.48

367

2431

Oedema, not elsewhere classified

413

2877

1.43

10.60

1.6

1.4

172.36

150.94

pmol/l

0.40

403

2798

Gastrointestinal stromal tumor and sarcoma

5.36

10.43

1.3

150.67

65.44

pmol/l

1.21

Bacterial infection, other or unspecified

580

3764

1.34

10.25

1.6

1.4

251.40

142.63

pmol/l

3.38

563

3669

Abnormalities of breathing

1286

6121

1.23

10.22

1.4

144.40

119.18

pmol/l

0.77

1248

5975

Gastro-oesophageal reflux disease

903

6194

1.26

10.05

1.4

152.14

133.86

pmol/l

0.39

882

6049

Explicit Sepsis

477

3248

1.38

10.04

1.6

1.4

199.97

157.24

pmol/l

1.09

466

3162

Cholelithiasis

1206

6804

1.23

9.99

1.4

117.68

136.30

pmol/l

1.00

1185

6642

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

341

2360

1.46

9.97

1.4

66.78

120.03

pmol/l

5.41

328

2298

Cardiovascular diseases

979

4194

1.26

9.93

1.5

1.4

120.62

77.29

pmol/l

1.60

952

4086

Certain infectious and parasitic diseases

1435

5956

1.21

9.90

1.4

138.52

113.35

pmol/l

1.10

1383

5822

Cholelithiasis, broad definition with cholecystitis

1235

6830

1.22

9.80

1.4

119.75

135.92

pmol/l

0.82

1214

6668

Degenerative diseases of the nervous system

113

1533

0.54

9.79

1.4

278.73

253.11

pmol/l

0.11

108

1482

Other disorders of skin and subcutaneous tissue

894

6334

1.26

9.76

1.5

1.4

106.20

147.13

pmol/l

4.57

869

6186

Leiomyosarcoma

5.34

9.74

1.9

1.4

68.48

66.44

pmol/l

0.05

Bacterial infection, other or unspecified

644

4167

1.31

9.68

1.6

1.4

239.43

138.15

pmol/l

3.50

625

4061

Anxiety disorders

1326

7661

1.21

9.65

1.5

1.4

125.02

123.70

pmol/l

0.03

1294

7468

Neurotic, stress-related and somatoform disorders

1316

7645

1.21

9.45

1.5

1.4

125.37

123.51

pmol/l

0.05

1284

7453

Pain, not elsewhere classified

396

2843

1.40

9.35

1.5

1.4

88.87

128.69

pmol/l

2.42

391

2763

Other special examinations and investigations of persons without complaint or reported diagnosis

830

3305

1.28

9.31

1.4

105.68

129.38

pmol/l

1.12

803

3240

Malignant neoplasm of other and ill-defined digestive organs

9.49

9.16

1.6

1.3

130.67

71.90

pmol/l

0.84

L02BG Aromatase inhibitors

566

4308

1.33

9.15

1.6

1.4

152.16

174.04

pmol/l

0.66

550

4204

Follow-up care involving plastic surgery

395

2.14

9.14

1.7

1.4

69.87

158.18

pmol/l

1.31

388

Other specific joint derangements/joint disorders

1059

5584

1.23

9.00

1.4

110.09

112.74

pmol/l

0.06

1032

5439

Dyspnoea

1189

7266

1.21

9.00

1.4

179.19

124.18

pmol/l

2.13

1157

7086

Disorders of thyroid, IBD co-morbidities

301

1443

1.48

8.96

1.3

1.4

104.80

125.29

pmol/l

0.38

293

1414

Dementia

187

2030

0.63

8.79

1.4

1.5

287.99

225.87

pmol/l

0.27

177

1973

Anxiety disorders, excluding more controls

1221

6592

1.21

8.78

1.5

1.4

130.44

125.21

pmol/l

0.13

1191

6433

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1256

6691

1.21

8.76

1.4

154.15

124.11

pmol/l

0.88

1231

6531

Other noninfective gastroenteritis and colitis

309

2148

1.45

8.75

1.4

109.18

160.39

pmol/l

1.73

301

2087

Diseases of oesophagus, stomach and duodenum

1436

7243

1.19

8.52

1.4

153.69

123.21

pmol/l

0.97

1401

7065

Coxibs

282

999

1.49

8.46

1.6

1.4

113.65

119.97

pmol/l

0.06

274

963

Codeine or tramadol medication

1566

7292

1.18

8.25

1.4

117.84

124.10

pmol/l

0.19

1515

7118

Hypertension, essential

1088

5077

1.22

8.23

1.5

1.4

150.94

111.79

pmol/l

1.44

1061

4969

N06DA Anticholinesterases

120

1628

0.58

8.20

1.4

179.41

259.56

pmol/l

0.65

114

1575

Use of anticholinesterases

120

1628

0.58

8.20

1.4

179.41

259.56

pmol/l

0.65

114

1575

Other and unspecified iron deficiency

427

3171

1.35

8.19

1.5

1.4

150.14

154.12

pmol/l

0.06

417

3073

Iron deficiency anaemia

534

4035

1.31

8.19

1.5

1.4

148.31

151.21

pmol/l

0.05

519

3926

Symptoms and signs involving the circulatory and respiratory systems

1445

6121

1.19

8.12

1.4

105.22

119.18

pmol/l

0.82

1402

5975

Malignant melanoma of skin

488

1.92

8.07

1.3

1.4

90.80

64.83

pmol/l

1.27

472

Any dementia

154

1720

0.62

7.93

1.4

1.5

339.46

233.98

pmol/l

0.41

147

1668

Secondary malignant neoplasm of other and unspecified sites

3.88

7.86

1.1

1.4

124.74

62.61

pmol/l

3.85

Endocrine, nutritional and metabolic diseases

1122

4725

1.21

7.63

1.5

1.4

133.24

101.14

pmol/l

1.10

1094

4608

Bacterial pneumoniae

224

2899

0.68

7.63

1.6

1.4

140.61

162.03

pmol/l

0.42

216

2819

General examination and investigation of persons without complaint and reported diagnosis

788

3303

1.25

7.56

1.5

1.4

152.16

129.31

pmol/l

0.43

768

3238

Persons encountering health services in circumstances related to reproduction

727

3920

1.25

7.53

1.5

1.4

129.48

128.54

pmol/l

0.01

711

3823

Dorsalgia

1362

6189

1.18

7.49

1.5

1.4

102.23

125.31

pmol/l

0.86

1322

6028

Recurrent or chronic depression

618

3433

1.27

7.26

1.4

99.89

120.74

pmol/l

0.81

603

3357

Acute tubulo-interstitial nephritis

830

5865

1.23

7.22

1.5

1.4

188.29

120.32

pmol/l

2.80

804

5719

Use of other anti-dementia drugs

1215

0.54

7.18

1.4

238.85

273.87

pmol/l

0.17

1168

Use of memantine

1215

0.54

7.18

1.4

238.85

273.87

pmol/l

0.17

1168

Nutritional anaemias

597

4558

1.27

7.14

1.5

1.4

160.16

150.07

pmol/l

0.17

582

4439

Dementia, including avohilmo

216

2171

0.68

7.09

1.4

1.5

271.23

224.37

pmol/l

0.23

205

2112

Contraceptive management

596

3298

1.27

7.08

1.5

1.4

99.95

114.43

pmol/l

0.30

585

3228

Angina pectoris

354

3177

0.74

7.06

1.4

143.55

178.05

pmol/l

1.06

346

3098

Bacterial pneumonia (organism specified)

239

3094

0.70

7.04

1.6

1.4

149.50

159.10

pmol/l

0.15

231

3007

Benign neoplasm of colon, rectum, anus and anal canal

679

4759

1.24

6.81

1.4

144.54

168.56

pmol/l

0.79

665

4637

Any dementia, excluding more controls

150

1609

0.64

6.80

1.4

1.5

342.34

226.34

pmol/l

0.45

143

1568

Coronary atherosclerosis

436

3590

0.77

6.78

1.4

156.13

173.71

pmol/l

0.51

424

3503

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

309

2.05

6.68

1.3

1.4

233.94

68.39

pmol/l

0.83

297

Neurological diseases, wide definition

418

1581

1.33

6.64

1.4

147.70

117.97

pmol/l

0.32

404

1545

Diseases of arteries, arterioles and capillaries

404

3900

0.76

6.60

1.5

1.4

167.43

170.56

pmol/l

0.05

390

3801

Bacterial pneumonia, not elsewhere classified

214

2710

0.69

6.60

1.6

1.4

144.51

166.17

pmol/l

0.40

206

2633

Other diseases of anus and rectum

335

2484

1.35

6.53

1.4

175.77

155.20

pmol/l

0.20

321

2418

Hypertensive diseases (excluding secondary)

791

3766

1.23

6.52

1.5

1.4

152.56

90.40

pmol/l

2.08

774

3685

Atrophic disorders of skin

246

1743

1.43

6.51

1.5

1.4

89.06

176.13

pmol/l

5.81

239

1704

Malignant neoplasm of uterus, part unspecified, including Hilmo

7.01

6.49

1.3

167.54

76.02

pmol/l

0.52

Migraine

886

5995

1.20

6.40

1.4

70.18

121.93

pmol/l

10.34

855

5852

Triptan medication for migraine, single purchase ok

1216

7049

1.17

6.35

1.4

78.61

124.97

pmol/l

7.84

1185

6870

Migraine, single triptan purchase ok & required. ICD-code if available is included

1216

7049

1.17

6.35

1.4

78.61

124.97

pmol/l

7.84

1185

6870

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

715

3679

1.23

6.34

1.4

145.11

90.64

pmol/l

1.66

700

3599

Organic, including symptomatic, mental disorders

268

2627

0.72

6.30

1.5

251.33

200.46

pmol/l

0.32

257

2558

Other bacterial diseases

1146

6568

1.18

6.24

1.5

1.4

214.45

122.56

pmol/l

4.95

1113

6416

Other reaction to severe stress, and adjustment disorders

577

4638

1.25

6.22

1.5

1.4

143.67

102.91

pmol/l

1.01

563

4515

Chronic diseases of tonsils and adenoids

1146

6177

1.18

6.20

1.4

85.18

129.37

pmol/l

4.85

1113

6031

Depression or dysthymia

853

3905

1.21

6.18

1.4

124.50

135.38

pmol/l

0.24

830

3816

Stroke, including SAH

400

3761

0.77

6.17

1.5

1.4

222.23

170.46

pmol/l

0.54

392

3663

Female infertility, uterine origin

6.50

6.16

1.7

1.4

64.40

85.28

pmol/l

0.31

Benign neoplasm of other and unspecified endocrine glands

168

1119

1.52

6.13

1.6

1.5

100.38

169.57

pmol/l

2.29

163

1097

Phlebitis and thrombophlebitis (not including DVT)

272

1987

1.38

5.99

1.4

223.70

155.28

pmol/l

0.69

261

1931

Peripheral artery disease

170

1991

0.68

5.93

1.5

1.4

233.97

221.74

pmol/l

0.10

164

1928

Other bacterial diseases

1302

7141

1.16

5.92

1.5

1.4

186.99

117.46

pmol/l

4.18

1265

6968

Diarrhoea and gastroenteritis of presumed infectious origin

1336

7635

1.16

5.88

1.4

123.46

125.69

pmol/l

0.05

1285

7455

Hypothyroidism, drug reimbursement

218

1079

1.44

5.82

1.5

1.4

64.51

46.91

pmol/l

4.27

212

1058

Haematosalpinx/Haematoma of broad ligament

9.77

5.80

2.7

1.5

53.18

98.00

pmol/l

0.45

Unspecified urinary incontinence

141

920

1.55

5.73

1.4

1.5

78.93

186.58

pmol/l

5.48

132

895

Squamous cell neoplasms and carcinomas of the skin

187

2.26

5.72

1.5

1.4

164.93

75.17

pmol/l

2.09

180

Other degenerative diseases of the nervous system

188

2013

0.69

5.71

1.4

166.85

163.83

pmol/l

0.02

182

1963

Acetic acid derivatives and related substances

266

995

1.39

5.70

1.5

1.4

199.14

120.32

pmol/l

0.79

259

959

Injuries to the head

1147

8180

0.86

5.70

1.4

121.79

125.31

pmol/l

0.10

1104

7982

DVT of lower extremities

195

1360

1.44

5.64

1.4

1.5

307.67

178.36

pmol/l

0.89

188

1319

Marginal zone B-cell lymphoma, including Hilmo

3.36

5.63

1.4

1.3

116.00

62.66

pmol/l

1.44

Other embolism and thrombosis

146

964

1.53

5.58

1.5

1.4

167.39

183.80

pmol/l

0.17

137

940

Depression

1311

7730

1.15

5.54

1.4

103.48

128.07

pmol/l

1.60

1276

7538

Benign neoplasm: Colon

545

4209

1.24

5.53

1.4

142.82

176.72

pmol/l

1.18

531

4099

Noninfective enteritis and colitis

554

4490

1.24

5.50

1.4

92.16

131.44

pmol/l

2.70

539

4370

Propionic acid derivatives

274

1003

1.38

5.50

1.4

197.71

119.72

pmol/l

0.66

266

966

Persons encountering health services for examination and investigation

792

3305

1.20

5.50

1.5

1.4

145.10

129.38

pmol/l

0.28

772

3240

Atherosclerosis, excluding cerebral and coronary sclerosis

151

1769

0.67

5.46

1.6

1.4

244.81

231.15

pmol/l

0.10

144

1710

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1003

6797

1.17

5.45

1.4

84.06

116.19

pmol/l

2.82

979

6634

Mood [affective] disorders

1378

7805

1.15

5.44

1.4

106.30

129.22

pmol/l

1.48

1339

7611

Malignant neoplasm of rectum

313

1.93

5.43

1.3

1.4

174.25

66.87

pmol/l

0.58

303

Stroke, excluding SAH

365

3429

0.77

5.39

1.5

1.4

240.85

177.21

pmol/l

0.63

357

3342

Mood disorders

1378

7807

1.14

5.30

1.4

106.20

129.23

pmol/l

1.49

1339

7613

Malignant neoplasm of vulva, including Hilmo

2.88

5.22

1.3

1.4

102.08

59.52

pmol/l

1.42

Endometriosis in cutaneous scar

6.84

5.22

1.8

1.3

41.17

80.53

pmol/l

0.63

Acute renal failure

160

1093

1.47

5.18

1.8

1.4

357.05

197.13

pmol/l

2.16

150

1064

Hepatomegaly and splenomegaly, not elsewhere classified

3.87

5.14

1.5

1.3

100.27

64.65

pmol/l

0.68

Acute upper respiratory infections

1405

7603

1.14

5.13

1.5

1.4

110.74

131.24

pmol/l

1.19

1365

7419

Oxicams

217

879

1.41

5.09

1.4

199.06

129.91

pmol/l

0.63

210

850

Special screening examination for infectious and parasitic diseases

325

1832

1.31

5.08

1.4

80.74

89.24

pmol/l

0.16

308

1795

Malaise and fatigue

599

3970

1.22

5.06

1.5

1.4

199.66

131.94

pmol/l

1.38

576

3867

Ischaemic heart disease, wide definition

610

4567

0.82

5.02

1.4

194.97

162.76

pmol/l

0.45

594

4457

Adenocarcinoma and papilloma adenocarcinoma of rectum

294

1.92

5.00

1.3

1.4

252.46

66.53

pmol/l

0.83

283

Major coronary heart disease event

720

5173

0.84

5.00

1.4

195.92

155.00

pmol/l

0.70

709

5046

Other dorsopathies, not elsewhere classified

1349

6190

1.14

4.95

1.5

1.4

114.91

125.30

pmol/l

0.28

1311

6029

Inguinal hernia

233

2107

0.74

4.93

1.5

1.4

150.66

160.46

pmol/l

0.10

227

2041

Disorders of eyelid, lacrimal system and orbit

1112

7344

1.15

4.88

1.4

94.47

139.18

pmol/l

5.86

1086

7165

Sulfonylureas

128

1519

0.67

4.87

1.4

1.5

271.35

212.99

pmol/l

0.72

123

1474

Intestinal infectious diseases

1496

7559

1.13

4.87

1.4

131.86

126.18

pmol/l

0.14

1441

7381

Other antidepressants

1282

5750

1.14

4.81

1.4

129.00

126.69

pmol/l

0.04

1243

5609

Acute pharyngitis

161

1110

1.45

4.80

1.5

59.75

111.97

pmol/l

2.14

151

1082

Diseases of liver

354

2778

1.28

4.79

1.4

193.53

155.91

pmol/l

0.63

344

2708

Mesothelioma, including Hilmo

5.83

4.78

1.3

1.5

100.00

59.95

pmol/l

1.84

Atrial fibrillation and flutter

359

1817

1.29

4.77

1.4

210.87

120.74

pmol/l

1.12

345

1782

All anxiety disorders

899

6099

1.17

4.75

1.5

1.4

82.60

106.87

pmol/l

1.98

882

5948

Other chronic obstructive pulmonary disease, including avohilmo

286

3075

0.77

4.72

1.5

1.4

232.62

173.74

pmol/l

0.50

281

2998

Ischaemic Stroke, excluding all haemorrhages

331

3149

0.78

4.71

1.5

1.4

211.25

188.55

pmol/l

0.27

323

3066

Emergency coronary revascularization (for ACS)

710

5109

0.84

4.65

1.4

184.01

157.78

pmol/l

0.44

699

4984

Benign lipomatous neoplasm

338

2652

1.28

4.61

1.4

172.43

160.70

pmol/l

0.10

331

2578

Abnormalities of heart beat

470

3758

1.23

4.55

1.6

1.4

102.11

141.27

pmol/l

1.91

461

3668

187

1354

1.39

4.49

1.4

156.14

125.43

pmol/l

0.41

181

1321

Abnormal results of function studies

105

681

1.56

4.46

1.5

220.53

169.58

pmol/l

0.20

100

666

Selective serotonin reuptake inhibitors

1252

5750

1.14

4.43

1.5

1.4

119.44

126.69

pmol/l

0.21

1219

5609

Other heart diseases

658

3610

1.19

4.43

1.5

1.4

145.71

91.68

pmol/l

1.62

640

3530

Myalgia

361

2873

1.26

4.42

1.5

1.4

96.38

127.54

pmol/l

0.92

353

2800

Abnormal findings on diagnostic imaging of lung

434

3375

1.24

4.39

1.4

185.59

174.17

pmol/l

0.11

425

3291

Anti-inflammatory and antirheumatic products, non-steroids

265

1003

1.33

4.39

1.5

1.4

193.28

119.72

pmol/l

0.59

258

966

Cardiac arrhythmias

914

5135

1.16

4.33

1.4

133.47

97.86

pmol/l

1.07

880

5024

Hypertension

1060

5220

1.15

4.32

1.5

1.4

154.76

110.58

pmol/l

1.69

1035

5108

Non-invasive ventilation

316

2213

1.28

4.30

1.5

1.4

104.37

113.14

pmol/l

0.20

288

2157

Other disorders of fluid, electrolyte and acid-base balance

311

2322

1.28

4.26

1.7

1.4

298.24

173.06

pmol/l

1.41

296

2270

Hypertensive diseases

1059

5223

1.15

4.24

1.5

1.4

154.83

110.56

pmol/l

1.69

1034

5109

Infections of the skin and subcutaneous tissue

623

5207

1.19

4.22

1.5

1.4

148.41

122.36

pmol/l

0.43

607

5067

Single spontaneous delivery

586

3700

0.83

4.22

1.4

174.84

149.60

pmol/l

0.35

567

3595

Dorsopathies

1372

6191

1.13

4.20

1.5

1.4

104.11

125.28

pmol/l

1.18

1335

6030

Irritable bowel syndrome

405

3285

1.24

4.20

1.4

82.58

125.73

pmol/l

3.00

388

3206

Cerebrovascular diseases

553

4645

0.83

4.18

1.5

1.4

205.70

159.46

pmol/l

0.69

542

4528

Other anaemias

386

2957

1.24

4.18

1.6

1.4

201.29

184.84

pmol/l

0.23

372

2875

Certain infectious and parasitic diseases

1023

4467

1.15

4.15

1.4

146.70

120.42

pmol/l

0.74

993

4365

Other diseases of the digestive system

246

1881

1.31

4.11

1.7

1.4

143.79

197.77

pmol/l

1.26

239

1818

Malignant neoplasm of vagina, including Hilmo

4.83

4.07

1.2

104.83

67.61

pmol/l

0.66

Other and unspecified anaemias

379

2918

1.24

4.03

1.6

1.4

198.78

185.41

pmol/l

0.18

366

2838

Coronary revascularization (ANGIO or CABG)

685

4913

0.85

4.03

1.4

177.68

153.94

pmol/l

0.37

674

4796

Sleep disorders (combined)

1488

6988

1.12

4.03

1.4

105.67

135.04

pmol/l

2.02

1440

6818

Haemorrhoids and perianal venous thrombosis

339

2703

1.26

4.01

1.5

1.4

147.61

156.95

pmol/l

0.10

334

2638

Liposarcoma, including Hilmo

4.17

3.94

1.2

1.3

75.62

61.41

pmol/l

0.55

Diagnoses used for exclusion with ILD

223

1695

1.32

3.93

1.4

187.99

167.27

pmol/l

0.16

217

1658

Percutaneous Coronary Intervention

686

4910

0.85

3.89

1.4

172.90

154.01

pmol/l

0.29

675

4793

Asthma, unspecified (mode), excluding more controls

711

4562

1.17

3.88

1.5

1.4

196.66

113.36

pmol/l

1.84

698

4470

Factors influencing health status and contact with health services

260

1001

1.31

3.84

1.5

1.4

226.43

124.19

pmol/l

0.90

255

984

Asthma, unspecified (mode)

724

4688

1.17

3.83

1.5

1.4

197.02

118.13

pmol/l

1.73

710

4592

Other/unspecified dorsalgia

495

4103

1.20

3.80

1.5

1.4

100.18

144.26

pmol/l

3.33

483

3997

Inflammatory disease of cervix uteri

112

767

1.48

3.78

1.4

1.5

208.15

191.94

pmol/l

0.05

107

748

Coagulation defects, purpura and other haemorrhagic conditions

214

1629

1.32

3.77

1.5

1.4

135.94

148.25

pmol/l

0.22

208

1583

Noninfectious colitis NAS

162

1183

1.38

3.76

1.5

99.44

166.67

pmol/l

2.12

156

1154

Other heart diseases, wide

1252

6826

1.12

3.74

1.4

139.97

119.10

pmol/l

0.66

1206

6668

Polyuria

177

1312

1.36

3.72

1.4

90.02

161.52

pmol/l

2.09

166

1276

Atrial fibrillation and flutter with reimbursement

271

1345

1.29

3.71

1.4

257.97

139.24

pmol/l

1.13

261

1318

Mesothelioma

6.79

3.69

1.4

1.5

109.50

55.87

pmol/l

—

Anxiety (asthma-related co-morbidities)

884

5985

1.15

3.69

1.5

1.4

83.25

119.03

pmol/l

3.30

868

5837

External causes of morbidity and mortality

957

4203

1.14

3.66

1.4

111.06

132.41

pmol/l

0.65

935

4108

Asthma (mode)

1041

4918

1.14

3.64

1.5

1.4

147.61

115.42

pmol/l

0.74

1015

4819

Viral infections characterized by skin and mucous membrane lesions

1088

8263

1.13

3.62

1.4

99.49

128.58

pmol/l

3.24

1055

8053

Attention to artificial openings

150

2.09

3.58

1.8

1.4

210.71

283.23

pmol/l

0.24

150

Missing teeth due to accident, extraction or parodontitis

642

5194

1.17

3.58

1.4

142.81

158.95

pmol/l

0.24

626

5064

Renal failure

325

2316

1.24

3.55

1.8

1.4

329.16

202.53

pmol/l

3.45

305

2260

Disorders of other endocrine glands

561

4695

1.18

3.55

1.5

1.4

127.06

139.88

pmol/l

0.24

548

4564

All pneumoniae

1063

7985

0.89

3.52

1.5

1.4

153.56

122.81

pmol/l

1.30

1037

7787

Insulin medication

422

4265

0.83

3.52

1.4

176.55

135.12

pmol/l

1.22

407

4155

Varicose veins

777

5108

1.15

3.51

1.4

196.49

142.90

pmol/l

1.13

762

4988

Primary ovarian failure

259

1.83

3.51

1.6

1.4

67.37

132.94

pmol/l

0.78

253

Heart failure, not strict

776

4582

1.15

3.51

1.6

1.4

230.21

147.06

pmol/l

2.37

754

4474

Candidiasis

397

3283

1.22

3.49

1.4

1.5

110.43

143.39

pmol/l

0.88

388

3189

Delivery

601

3705

0.85

3.47

1.4

172.10

149.53

pmol/l

0.31

582

3599

Symptoms and signs involving the urinary system

827

5513

1.15

3.47

1.4

139.14

149.26

pmol/l

0.20

794

5385

Acute inflammation of orbit

3.65

3.46

1.3

1.2

62.87

63.63

pmol/l

0.02

Visual impairment including blindness (binocular or monocular)

441

1.60

3.46

1.4

1.5

230.83

211.90

pmol/l

0.08

430

Oter anti-inflammatory and antirheumatic agents, non-steroids

186

766

1.34

3.44

1.5

1.4

133.38

140.62

pmol/l

0.10

180

741

Purpura and other haemorrhagic conditions

137

990

1.39

3.43

1.6

1.5

156.26

170.29

pmol/l

0.17

132

967

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1021

7828

0.89

3.42

1.5

1.4

155.80

124.59

pmol/l

1.25

997

7632

Injury, poisoning and certain other consequences of external causes

800

3491

1.15

3.41

1.5

1.4

124.06

132.08

pmol/l

0.15

781

3412

Explicit bacterial Sepsis

595

1.50

3.37

1.4

185.76

191.21

pmol/l

0.03

581

Mood disorders, excluding more controls

1233

6601

1.12

3.36

1.4

111.25

125.26

pmol/l

0.65

1200

6442

Tonsillectomy and adenotomy

816

4976

1.14

3.35

1.4

63.28

96.00

pmol/l

4.94

789

4855

Excluding asthma or asthma-COPD overlap

1104

4924

1.13

3.33

1.5

1.4

148.63

114.84

pmol/l

1.28

1068

4822

Other neurological diseases

603

5501

0.86

3.33

1.5

1.4

153.70

150.07

pmol/l

0.06

581

5367

Other viral diseases

334

2721

1.23

3.31

1.4

84.00

109.93

pmol/l

1.20

321

2644

Diseases of the digestive system

425

3536

1.20

3.31

1.6

1.4

133.18

160.52

pmol/l

0.86

414

3433

Aplastic and other anaemias

410

3183

1.20

3.30

1.6

1.4

215.07

178.66

pmol/l

0.64

396

3097

Malignant neoplasm of vulva

2.75

3.27

1.2

1.4

87.06

63.59

pmol/l

0.97

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.65

3.26

1.6

1.3

76.12

57.67

pmol/l

0.47

Pneumonias (Asthma/COPD co-morbidities)

1058

7943

0.89

3.25

1.5

1.4

153.72

122.98

pmol/l

1.28

1032

7746

Exposure to other specified factors

718

7532

0.87

3.24

1.4

107.90

123.57

pmol/l

0.69

692

7342

Diseases of the skin and subcutaneous tissue

1310

5919

1.11

3.22

1.5

1.4

110.97

129.21

pmol/l

0.87

1267

5764

Functional dyspepsia

357

2950

1.22

3.20

1.5

1.4

108.08

140.18

pmol/l

1.26

348

2866

Car occupant injured in other and unspecified transport accidents

221

1732

1.28

3.19

1.5

95.31

126.59

pmol/l

0.70

210

1685

Umbilical hernia

216

1688

1.28

3.18

1.4

155.04

131.85

pmol/l

0.27

210

1641

Chronic apical periodontitis

1462

7559

1.10

3.16

1.4

130.79

122.26

pmol/l

0.31

1419

7368

Transient ischemic attack

355

3468

0.83

3.15

1.5

1.4

168.91

179.09

pmol/l

0.17

341

3382

Asthma (diagnoses ohter than nonallergic)

1103

8211

1.12

3.14

1.5

1.4

164.79

120.43

pmol/l

1.27

1080

7992

Kela-code for severe mental illness

279

3441

0.81

3.13

1.4

1.5

92.41

125.65

pmol/l

2.19

268

3351

COPD differential diagnosis

1098

4918

1.12

3.11

1.5

1.4

145.78

115.42

pmol/l

1.09

1062

4819

ILD differential diagnosis

1098

4918

1.12

3.11

1.5

1.4

145.78

115.42

pmol/l

1.09

1062

4819

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.86

3.11

1.9

1.3

129.57

59.65

pmol/l

0.63

Benign neoplasm of other and ill-defined parts of digestive system

198

1539

1.29

3.07

1.3

1.5

200.06

177.64

pmol/l

0.10

191

1503

Mucinous and mucinous cystic tumor of rectum

6.04

3.05

1.6

1.4

85.77

62.58

pmol/l

—

Obesity, other/unspecified

486

4149

1.18

3.04

1.5

1.4

107.20

114.21

pmol/l

0.16

466

4048

Glucosamine medication

531

3635

1.17

3.03

1.4

1.5

156.06

196.45

pmol/l

1.32

516

3545

Antihypertensive medication - note that there are other indications

891

4185

1.13

2.99

1.5

1.4

117.21

88.05

pmol/l

0.78

869

4072

Acquired atrophy of ovary and fallopian tube

5.00

2.98

2.0

1.2

53.38

89.88

pmol/l

—

Other diseases of upper respiratory tract

1385

6556

1.10

2.95

1.5

1.4

109.53

136.58

pmol/l

1.97

1343

6396

Malignant neoplasm of vagina

5.86

2.95

1.1

1.2

139.71

76.72

pmol/l

—

Chronic laryngitis and laryngotracheitis

167

1278

1.32

2.94

1.5

1.4

94.42

170.36

pmol/l

2.80

160

1251

Ischemic heart diseases

775

5264

0.88

2.89

1.4

171.72

150.98

pmol/l

0.45

758

5139

Myelodysplastic syndrome, including Hilmo

2.45

2.88

1.4

135.00

67.18

pmol/l

0.87

Other anxiety disorders

659

5001

1.15

2.88

1.5

1.4

80.74

101.21

pmol/l

1.24

645

4869

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.52

2.88

1.7

1.5

181.31

67.07

pmol/l

0.81

Chronic lymphocytic leukaemia

2.52

2.88

1.7

1.5

181.31

67.07

pmol/l

0.81

Chronic lymphocytic leukaemia, helper endpoint

2.52

2.88

1.7

1.5

181.31

67.07

pmol/l

0.81

Cough

513

4179

1.16

2.87

1.4

132.18

141.21

pmol/l

0.18

494

4080

Other disorders of lacrimal gland

483

4145

1.17

2.86

1.3

1.4

101.28

162.38

pmol/l

3.32

469

4041

Other disorders of skin and subcutaneous tissue, not elsewhere classified

148

1118

1.33

2.86

1.5

129.09

182.34

pmol/l

1.07

143

1094

Disorders of lacrimal system

588

5108

1.15

2.85

1.4

99.50

156.96

pmol/l

4.05

572

4980

Other pulmonary diagnosis

1093

4924

1.11

2.84

1.5

1.4

147.50

114.84

pmol/l

1.21

1057

4822

HSIL lesion of the cervix uteri, vagina or vulva

386

3262

1.19

2.80

1.4

1.5

84.69

99.79

pmol/l

0.46

381

3181

Other diseases of liver

198

1560

1.28

2.80

1.3

1.4

208.69

163.12

pmol/l

0.46

190

1522

Acute pancreatitis

157

1200

1.31

2.79

1.5

1.4

168.16

178.29

pmol/l

0.09

152

1178

Covid-19 confirmed case

356

2984

1.20

2.78

1.6

1.4

181.63

155.64

pmol/l

0.31

346

2892

Urolithiasis

220

1755

1.26

2.78

1.5

1.4

161.64

155.81

pmol/l

0.05

215

1710

Gastroduodenal ulcer

191

1494

1.28

2.78

1.4

197.75

193.93

pmol/l

0.04

183

1445

Benign neoplasm: Colon, unspecified

206

1632

1.27

2.77

1.4

123.91

210.35

pmol/l

3.14

200

1586

Presence of other devices

208

1644

1.26

2.76

1.4

145.87

197.18

pmol/l

1.07

198

1600

L01XX Other antineoplastic agents

341

1.60

2.72

1.6

1.5

359.91

292.62

pmol/l

0.26

335

GI-bleeding

229

1842

1.25

2.70

1.7

1.4

152.48

197.73

pmol/l

0.89

221

1779

Unspecified mental disorder

339

4033

0.84

2.69

1.4

89.82

121.30

pmol/l

2.36

328

3930

Other gastritis (incl. Duodenitis)

214

1711

1.26

2.68

1.5

1.4

198.78

172.10

pmol/l

0.14

209

1657

Premature rupture of membranes

447

2739

1.17

2.66

1.4

58.65

87.20

pmol/l

2.18

435

2674

Vascular dementia

338

0.45

2.66

1.6

1.5

129.81

291.28

pmol/l

1.71

327

Hard cardiovascular diseases

821

5485

0.89

2.65

1.4

168.46

143.46

pmol/l

0.60

805

5351

Fibromyalgia

172

1345

1.29

2.64

1.4

95.75

130.00

pmol/l

0.94

164

1312

Metabolic disorders

1158

6412

1.10

2.63

1.5

1.4

170.04

124.11

pmol/l

2.27

1121

6280

Non-small cell lung cancer, adenocarcinoma

191

1.79

2.62

1.4

185.15

73.62

pmol/l

1.04

184

Other viral diseases

461

3941

1.16

2.62

1.4

75.39

105.25

pmol/l

2.39

446

3835

Acute pancreatitis (for exclusion)

157

1212

1.30

2.62

1.5

168.16

168.50

pmol/l

0.00

152

1188

Abnormal findings in secretions and smears from cervix uteri vagina vulva

985

6718

1.11

2.62

1.4

82.27

115.74

pmol/l

2.98

960

6558

Asthma (only as main-diagnosis)

940

4886

1.12

2.60

1.5

1.4

108.83

115.18

pmol/l

0.17

919

4787

Unspecified haematuria

279

1905

1.22

2.58

1.4

164.26

179.67

pmol/l

0.14

269

1856

Peripheral artery operations in Hilmo

478

0.54

2.58

1.5

312.54

255.50

pmol/l

0.11

465

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

7.41

2.57

1.4

1.1

156.24

60.77

pmol/l

—

Zoster [herpes zoster]

572

4932

1.14

2.57

1.5

1.4

112.59

160.64

pmol/l

4.30

554

4809

Dental pulpitis, including avohilmo

1194

7058

1.10

2.56

1.4

109.76

114.79

pmol/l

0.11

1155

6885

Asthma

1032

4886

1.11

2.54

1.5

1.4

133.71

115.18

pmol/l

0.41

1005

4787

Symptoms and signs involving the skin and subcutaneous tissue

890

7839

1.11

2.54

1.4

121.69

130.25

pmol/l

0.25

869

7644

Other intervertebral disc disorders

1048

5710

1.11

2.53

1.4

134.49

132.07

pmol/l

0.06

1014

5573

Infections with a predominantly sexual mode of transmission

449

3868

1.16

2.53

1.4

76.13

103.84

pmol/l

2.37

434

3771

Sequelae of cerebrovascular disease

176

1919

0.79

2.52

1.5

1.4

246.52

207.20

pmol/l

0.32

170

1863

Radiculopathy

164

1281

1.29

2.52

1.4

131.03

197.71

pmol/l

1.80

157

1242

Marginal zone B-cell lymphoma

3.04

2.51

1.3

1.4

84.64

68.19

pmol/l

0.38

Adjustment and management of implanted device

115

856

1.35

2.49

1.5

1.4

233.37

161.29

pmol/l

0.49

108

835

Gout, strict definition

494

1.46

2.48

1.5

247.69

247.16

pmol/l

0.00

481

Liposarcoma

3.90

2.48

1.3

75.63

53.71

pmol/l

—

Calculus of kidney and ureter

208

1674

1.25

2.48

1.5

1.4

167.29

156.71

pmol/l

0.10

203

1633

Injuries to the shoulder and upper arm

751

6766

0.89

2.46

1.5

1.4

136.77

138.61

pmol/l

0.04

735

6588

All dysplastic lesions of the cervix uteri, vagina or vulva

570

4941

1.14

2.45

1.4

78.97

100.13

pmol/l

1.21

563

4814

Obstructed labour due to malposition and malpresentation of fetus

335

3683

0.84

2.45

1.4

95.69

89.53

pmol/l

0.05

327

3599

Tongue abnormality

522

1.45

2.45

1.4

1.5

144.23

226.03

pmol/l

0.89

508

Other benign neoplasms of skin

416

3579

1.17

2.44

1.5

1.4

125.46

158.18

pmol/l

0.97

409

3480

Fibrosis and cirrhosis of liver

522

1.45

2.44

1.5

130.48

227.83

pmol/l

1.48

511

Asthma, excluding more controls

1008

4757

1.11

2.41

1.5

1.4

129.33

110.58

pmol/l

0.41

982

4662

Adenocarcinoma of small intestine

6.52

2.40

1.0

1.5

78.20

63.30

pmol/l

—

Abnormal findings on examination of blood, without diagnosis

319

2467

1.19

2.38

1.6

1.4

201.94

152.81

pmol/l

0.45

309

2395

Ulcerative colitis

254

2099

1.21

2.38

1.4

72.47

137.11

pmol/l

5.50

249

2043

Autoimmune diseases related-to ILD

1041

8104

1.10

2.37

1.4

100.17

129.63

pmol/l

2.76

1015

7897

L01XE Protein kinase inhibitors

338

1.55

2.36

1.4

1.5

117.48

233.49

pmol/l

1.44

333

Other benign neoplasm of uterus: Other parts/unspecified

396

1.51

2.34

1.5

1.4

102.67

301.95

pmol/l

3.56

382

Inflammatory bowel disease

332

2817

1.18

2.33

1.3

1.4

71.13

128.12

pmol/l

6.70

323

2743

Gout, idiopatic and unspecified

109

814

1.34

2.33

1.6

1.4

205.89

227.77

pmol/l

0.20

109

788

Implicit viral Sepsis

271

2258

1.20

2.32

1.5

1.4

138.50

175.79

pmol/l

1.01

256

2190

Malignant neoplasm of bladder, including Hilmo

168

1.78

2.31

1.5

1.4

136.60

66.56

pmol/l

1.33

162

Malignant neoplasm of rectosigmoid junction, including Hilmo

2.14

2.29

1.2

1.5

342.20

63.84

pmol/l

0.57

Asthma (only as main-diagnosis), excluding more controls

920

4757

1.11

2.28

1.5

1.4

107.01

110.58

pmol/l

0.09

899

4662

Disorders of skin appendages

590

5221

1.13

2.28

1.4

101.67

120.82

pmol/l

0.69

577

5082

Triptan medication for migraine, min. 3 purchases

957

6634

1.10

2.28

1.4

70.37

110.08

pmol/l

6.18

930

6474

Other viral diseases, not elsewhere classified

195

1573

1.24

2.27

1.5

89.91

129.55

pmol/l

1.21

188

1534

Obesity related asthma

400

3456

1.16

2.25

1.5

1.4

135.86

134.84

pmol/l

0.02

390

3372

Other predominantly sexually transmitted diseases, not elsewhere classified

246

2042

1.21

2.24

1.3

1.5

71.21

109.61

pmol/l

2.10

238

1992

Pneumonia, organism unspecified

937

7222

0.91

2.23

1.5

1.4

153.39

126.53

pmol/l

0.94

914

7048

Type 1 diabetes, strict (exclude DM2)

700

0.65

2.23

1.4

72.70

94.07

pmol/l

0.47

682

Ulcerative enterocolitis

225

1.66

2.23

1.5

1.4

65.14

178.06

pmol/l

0.92

220

HSIL lesion of the cervix uteri

350

3000

1.17

2.23

1.4

1.5

82.37

97.19

pmol/l

0.41

345

2929

Dislocation, sprain and strain of joints and ligaments of knee

602

6234

0.89

2.22

1.3

1.4

96.12

118.15

pmol/l

1.24

579

6092

Periodontal disease, other/unspecified

210

1.69

2.22

1.4

1.5

73.74

183.07

pmol/l

1.01

203

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

2.53

2.19

1.2

1.4

92.33

63.36

pmol/l

0.92

Dentofacial anomalies [including malocclusion]

1016

7453

1.10

2.17

1.4

70.51

122.83

pmol/l

11.87

989

7271

1512

7237

1.08

2.17

1.5

1.4

120.54

126.86

pmol/l

0.21

1463

7066

Retention of urine

186

1232

1.24

2.16

1.5

189.21

163.13

pmol/l

0.18

181

1193

Visual disturbances and blindness

600

5341

1.13

2.15

1.4

128.38

141.85

pmol/l

0.36

580

5201

Oral corticosteroids

1347

7378

1.08

2.15

1.4

156.19

122.04

pmol/l

1.30

1316

7190

Type 1 diabetes, definitions combined

705

0.66

2.14

1.4

71.87

94.25

pmol/l

0.50

687

Cervicalgia

255

2134

1.20

2.14

1.4

96.06

167.43

pmol/l

3.43

249

2068

Chronic gastritis

269

2261

1.19

2.14

1.6

1.4

160.55

182.66

pmol/l

0.30

263

2195

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

672

1.36

2.13

1.6

1.5

172.38

211.94

pmol/l

0.43

658

Other arrhythmias

816

5571

1.11

2.11

1.4

119.94

129.65

pmol/l

0.26

786

5447

Nontoxic goitre/thyroid nodule

428

3739

1.15

2.11

1.5

1.4

114.64

168.31

pmol/l

2.66

420

3641

Other congenital malformations of upper alimentary tract

2.63

2.10

1.2

1.3

98.73

97.80

pmol/l

0.01

Personal history of malignant neoplasm

103

779

1.33

2.10

1.4

103.38

176.85

pmol/l

1.54

766

Episodal and paroxysmal disorders

1434

6758

1.08

2.09

1.4

97.90

129.84

pmol/l

3.34

1385

6591

Non-small cell lung cancer

250

1.59

2.09

1.3

1.4

174.49

73.76

pmol/l

1.14

240

Abnormal serum enzyme levels

107

791

1.32

2.08

1.4

1.5

107.07

180.78

pmol/l

1.19

107

776

Otitis externa

236

1967

1.20

2.08

1.4

144.91

140.29

pmol/l

0.05

226

1916

Myelodysplastic syndrome

3.54

2.06

1.0

1.2

201.71

79.22

pmol/l

—

Delivery, wide proxy

506

3043

0.88

2.05

1.4

170.93

154.77

pmol/l

0.19

488

2953

Noise effects on inner ear

0.00

2.04

0.0

1.5

—

87.01

—

Other other unspecified disorders of the circulatory system

255

1.59

2.02

1.4

1.5

148.17

268.69

pmol/l

0.74

250

Nephropathy related operations

576

1.38

2.02

1.7

1.5

492.56

208.27

pmol/l

3.17

566

Chronic kidney disease

182

1454

1.23

2.01

1.7

1.4

357.69

216.42

pmol/l

3.12

169

1417

Diseases of pulp and periapical tissues, including avohilmo

1344

6447

1.08

1.98

1.4

130.02

124.23

pmol/l

0.16

1302

6279

Hirsutism in women

250

1.59

1.96

1.5

1.3

48.90

111.09

pmol/l

0.82

243

Asthma, including avohilmo

1470

7678

1.08

1.96

1.4

135.70

122.72

pmol/l

0.33

1431

7478

Malignant neoplasm of thymus

3.89

1.96

1.0

1.3

189.33

51.85

pmol/l

—

Neuroendocrine tumor and carcinoma of lung

2.50

1.95

1.1

1.3

139.18

65.50

pmol/l

0.79

Iron deficiency anaemia secondary to blood loss (chronic)

157

1265

1.25

1.95

1.5

1.4

172.98

167.34

pmol/l

0.07

151

1227

Crohn's disease of small intestine

564

1.37

1.94

1.4

1.5

73.10

147.27

pmol/l

1.64

553

Melanocytic naevi, other sites/unspecified

676

1.34

1.93

1.4

1.5

97.17

159.75

pmol/l

0.64

664

Hypertrichosis

275

1.55

1.93

1.4

1.3

56.55

126.42

pmol/l

0.92

267

Influenza and pneumonia

1170

8043

0.92

1.93

1.5

1.4

136.82

121.29

pmol/l

0.72

1139

7840

Migraine without aura

338

2927

1.16

1.92

1.4

1.5

60.71

107.90

pmol/l

5.14

327

2862

Other and unspecified injuries of ankle and foot

356

1.47

1.91

1.3

1.4

81.55

147.85

pmol/l

0.75

346

Cutaneous abscess, furuncle and carbuncle

251

2124

1.19

1.89

1.5

1.4

107.07

131.90

pmol/l

0.79

244

2069

Explicit fungal Sepsis

2.92

1.88

1.9

1.3

173.25

68.25

pmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

299

2571

1.17

1.86

1.4

137.28

133.74

pmol/l

0.03

290

2514

Glucagon-like peptide-1 (GLP-1) analogues

299

2571

1.17

1.86

1.4

137.28

133.74

pmol/l

0.03

290

2514

Antenatal screening

337

2181

0.86

1.84

1.4

53.37

80.84

pmol/l

2.85

327

2128

161

1231

1.23

1.83

1.4

199.89

262.43

pmol/l

0.86

152

1190

Type 1 diabetes

157

1922

0.81

1.83

1.4

174.29

121.67

pmol/l

0.79

152

1868

Alzheimer’s disease (Early onset), excluding more controls

235

0.48

1.83

1.6

111.08

262.41

pmol/l

1.78

227

Isolated growth hormone deficiency

3.10

1.81

2.3

1.5

91.29

47.43

pmol/l

—

Type 1 diabetes, strict definition

571

0.66

1.80

1.4

66.84

88.08

pmol/l

0.37

555

Other CVD

142

1143

1.25

1.79

1.4

1.5

167.85

214.88

pmol/l

0.64

137

1107

Second line medication for Crohn's disease

589

6528

0.90

1.79

1.4

130.75

133.47

pmol/l

0.04

571

6376

Melanocytic naevi

351

3065

1.15

1.79

1.5

1.4

82.14

130.07

pmol/l

2.91

342

2983

Use of hypnotics and sedatives

1312

7008

1.08

1.78

1.4

135.01

124.76

pmol/l

0.29

1277

6846

Other obstructive and reflux uropathy

321

1.48

1.77

2.0

1.4

297.75

117.61

pmol/l

0.89

313

Anankastic personality disorder

386

0.59

1.76

1.6

1.4

44.30

116.24

pmol/l

1.62

376

Ectopic pregnancy

321

2792

1.16

1.76

1.3

1.4

112.64

120.91

pmol/l

0.13

314

2736

Malignant neoplasm of thymus, including Hilmo

3.42

1.76

1.0

1.3

189.33

51.81

pmol/l

—

Sub-endpoint used in defining T1D endpoints

169

2014

0.82

1.76

1.4

1.5

185.47

134.81

pmol/l

0.78

162

1957

Statin medication

827

5081

0.91

1.76

1.4

166.82

111.16

pmol/l

1.37

802

4977

Neurological diseases

1172

5455

1.08

1.76

1.4

130.15

122.03

pmol/l

0.18

1132

5325

Gonarthrosis [arthrosis of knee](FG)

750

4785

0.91

1.76

1.4

170.10

137.88

pmol/l

0.64

732

4686

L04AX Other immunosuppressants

569

6308

0.90

1.75

1.4

132.94

134.60

pmol/l

0.02

552

6164

Reimbursement for rheumatic diseases

604

6649

0.90

1.75

1.5

1.4

159.82

136.68

pmol/l

0.40

586

6492

Type 1 diabetes, wide definition

141

1735

0.81

1.74

1.4

160.48

119.42

pmol/l

0.53

135

1687

Pneumothorax

281

1.50

1.74

1.5

181.21

214.12

pmol/l

0.15

275

All influenza

213

1793

1.19

1.73

1.7

1.4

188.15

153.07

pmol/l

0.27

201

1742

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

295

3403

0.86

1.73

1.3

1.5

72.41

104.65

pmol/l

3.03

288

3313

Caries of enamel

1154

7729

1.08

1.73

1.3

1.4

90.54

126.66

pmol/l

2.79

1127

7532

375

3751

0.88

1.72

1.5

1.4

178.02

119.43

pmol/l

0.88

365

3654

All influenza (not pneumonia)

121

962

1.26

1.72

1.8

1.5

227.92

160.38

pmol/l

0.32

115

938

Pain in throat and chest

1058

5875

1.08

1.72

1.4

99.29

122.41

pmol/l

1.46

1032

5737

Mycoses

1026

8260

1.08

1.70

1.4

105.03

127.43

pmol/l

1.19

1000

8046

Soft tissue disorders

1297

6221

1.07

1.69

1.5

1.4

125.14

124.08

pmol/l

0.02

1255

6067

Other joint disorders

1143

5591

1.08

1.69

1.4

115.51

112.89

pmol/l

0.06

1108

5446

Insulin, combination of fast acting with intermediate-acting or long-acting

422

4338

0.89

1.68

1.4

176.55

144.84

pmol/l

0.79

407

4225

Viral and other specified intestinal infections

199

1632

1.19

1.67

1.4

1.5

72.02

119.36

pmol/l

2.54

187

1584

Malignant neoplasm of gallbladder, including Hilmo

2.85

1.66

1.1

1.2

95.57

74.26

pmol/l

—

Diseases of appendix

891

7403

1.09

1.66

1.4

94.83

123.23

pmol/l

1.83

865

7230

Nerve, nerve root and plexus disorders

1313

7509

1.07

1.65

1.4

132.51

128.00

pmol/l

0.10

1280

7329

Type 1 diabetes, strict definition, subgroup 1

536

0.67

1.65

1.4

68.64

79.39

pmol/l

0.17

520

Other inflammatory liver diseases

495

1.36

1.65

1.4

1.5

109.76

200.00

pmol/l

1.42

485

Disorders of conjunctiva

1103

8229

1.08

1.65

1.4

99.35

128.51

pmol/l

2.31

1083

8008

All dysplastic lesions of the cervix uteri

490

4363

1.12

1.64

1.4

79.21

96.16

pmol/l

0.73

484

4256

Disorders of breast

917

7696

1.08

1.62

1.4

137.36

130.25

pmol/l

0.13

893

7512

Diseases of pulp and periapical tissues and dental caries

791

3710

1.09

1.61

1.5

1.4

151.63

140.49

pmol/l

0.20

769

3614

Intracranial trauma

628

4855

0.91

1.61

1.4

108.78

121.97

pmol/l

0.51

605

4743

Type 1 diabetes, wide definition, subgroup 1

135

1650

0.81

1.59

1.5

1.4

162.98

118.15

pmol/l

0.57

130

1606

218

1614

1.18

1.58

1.4

1.5

192.71

244.24

pmol/l

0.88

205

1569

Gout, unspecified

646

1.30

1.57

1.4

1.5

183.43

255.81

pmol/l

0.92

624

Gastric ulcer

131

1064

1.23

1.57

1.4

1.5

169.08

178.69

pmol/l

0.10

123

1033

STROKE

552

4146

0.90

1.56

1.5

1.4

177.44

143.51

pmol/l

0.49

536

4046

Other viral diseases, not elsewhere classified

303

2634

1.15

1.56

1.5

1.4

75.88

110.26

pmol/l

1.99

295

2563

Other symptoms and signs involving cognitive functions and awareness

342

3528

0.88

1.56

1.4

158.81

167.80

pmol/l

0.13

330

3435

Presence of cardiac and vascular implants and grafts

201

1762

0.85

1.56

1.5

1.4

174.16

226.07

pmol/l

0.77

194

1716

Diarrhoea and gastroenteritis of presumed infectious origin

812

6740

1.09

1.54

1.4

140.27

118.87

pmol/l

0.46

774

6570

ILD medications: prednisolone, methylprednisolone, prednisone

1372

7196

1.07

1.53

1.4

137.42

120.49

pmol/l

0.62

1342

7012

Malignant neoplasm of gallbladder

3.40

1.53

1.2

1.3

113.00

68.16

pmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

312

2739

1.14

1.52

1.4

88.78

115.04

pmol/l

1.31

301

2665

Maternal care for other conditions predominantly related to pregnancy

316

3517

0.88

1.52

1.3

1.4

69.98

88.58

pmol/l

1.22

307

3437

Hypo-osmolality and hyponatraemia

158

1307

1.21

1.51

1.7

1.4

346.37

196.76

pmol/l

0.73

149

1276

Familial hypercholesterolemia

104

828

1.26

1.50

1.7

1.5

244.14

208.99

pmol/l

0.25

806

Osteopathies and chondropathies

647

5510

1.10

1.50

1.4

131.21

151.06

pmol/l

0.93

628

5369

Seborrhoeic keratosis

218

1868

1.17

1.49

1.4

1.5

120.27

205.99

pmol/l

2.74

211

1822

Struck by thrown, projected or falling objec

256

0.54

1.49

1.4

52.14

125.80

pmol/l

1.03

249

Other disorders of bladder

556

1.32

1.49

1.5

99.41

170.14

pmol/l

1.59

546

Assault by hanging, strangulation and suffocation

2.61

1.48

1.4

1.5

133.00

51.74

pmol/l

—

Follicular adenocarcinoma of thyroid gland

2.42

1.47

1.9

1.3

54.11

62.11

pmol/l

—

Codes for special purposes

590

5371

1.10

1.47

1.5

1.4

152.51

126.80

pmol/l

0.54

576

5220

Provisional assignment of new diseases of uncertain etiology

589

5362

1.10

1.47

1.5

1.4

152.61

126.91

pmol/l

0.54

575

5212

Systemic connective tissue disorders

439

3946

1.12

1.47

1.6

1.4

116.36

154.97

pmol/l

1.87

430

3844

Other disorders of kidney and ureter

101

805

1.26

1.46

1.8

1.5

197.37

207.87

pmol/l

0.09

785

Implicit viral Sepsis

166

1393

1.19

1.46

1.5

1.4

159.94

172.88

pmol/l

0.16

156

1350

Certolizumab pegol

201

0.49

1.46

1.6

1.4

58.80

150.10

pmol/l

—

194

Hypokalaemia

123

1003

1.23

1.46

1.6

1.4

150.11

170.58

pmol/l

0.31

118

977

Heart failure and antihypertensive medication

218

1220

1.17

1.44

1.5

1.4

255.19

150.09

pmol/l

1.13

211

1193

Pilonidal cyst

525

1.32

1.43

1.5

1.4

123.07

95.82

pmol/l

0.16

512

Substance abuse, excluding more controls

409

3886

0.90

1.43

1.5

1.4

135.80

115.11

pmol/l

0.38

401

3787

Gestational [pregnancy-induced] hypertension

399

4435

0.89

1.43

1.3

1.4

63.12

100.44

pmol/l

6.07

387

4324

Viral Sepsis

166

1397

1.19

1.42

1.5

1.4

159.94

172.51

pmol/l

0.16

156

1354

Acute suppurative otitis media

292

2394

1.14

1.42

1.4

1.5

72.17

94.60

pmol/l

0.90

273

2333

Infections with a predominantly sexual mode of transmission

551

4675

1.10

1.41

1.4

70.59

96.60

pmol/l

2.91

531

4552

Other headache syndromes

617

5647

1.09

1.41

1.4

97.47

132.00

pmol/l

1.21

601

5520

Dialysis, with operation codes

605

1.29

1.41

1.7

1.5

494.55

209.66

pmol/l

3.21

594

Visual disturbances

549

5009

1.10

1.38

1.4

115.64

141.76

pmol/l

0.99

534

4881

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

2.66

1.38

3.0

1.2

186.67

59.32

pmol/l

—

Other arthrosis

582

3682

1.10

1.36

1.4

139.96

145.09

pmol/l

0.12

565

3599

Other specified/unspecified hearing loss

584

0.72

1.36

1.4

1.5

242.91

214.82

pmol/l

0.11

574

1033

6687

0.93

1.36

1.5

1.4

141.46

125.96

pmol/l

0.62

1007

6532

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1033

6687

0.93

1.36

1.5

1.4

141.46

125.96

pmol/l

0.62

1007

6532

Disorders of magnesium metabolism

2.17

1.35

1.3

1.6

163.90

290.89

pmol/l

—

Sciatica+with lumbago

637

5386

1.09

1.35

1.4

115.60

136.16

pmol/l

0.34

611

5257

Caries of dentine, including avohilmo

948

4508

1.08

1.35

1.5

1.4

145.70

134.99

pmol/l

0.21

917

4394

Injuries to the wrist and hand

1098

8108

0.94

1.34

1.4

111.23

124.37

pmol/l

0.39

1065

7903

Implicit parasitic Sepsis

0.00

1.34

0.0

1.4

—

84.52

—

Nontoxic multinodular goitre

272

2393

1.14

1.34

1.5

1.4

135.63

174.46

pmol/l

0.90

266

2327

Rheumatoid arthritis, including avohilmo

380

4229

0.90

1.34

1.5

1.4

208.25

150.81

pmol/l

0.71

371

4118

Benign neoplasm: Caecum

726

1.26

1.33

1.5

195.79

227.29

pmol/l

0.21

710

Urticaria and erythema

475

4313

1.10

1.33

1.4

110.28

125.83

pmol/l

0.44

459

4203

Fitting and adjustment of other devices

285

2267

1.14

1.33

1.6

1.4

171.84

137.11

pmol/l

0.66

272

2224

Polyarthrosis

269

2195

1.14

1.33

1.5

149.34

186.52

pmol/l

0.89

263

2137

Viral infections characterized by skin and mucous membrane lesions

427

3854

1.11

1.33

1.5

1.4

100.38

141.19

pmol/l

3.15

417

3744

Viral and other specified intestinal infections

286

2435

1.14

1.32

1.4

1.5

129.85

107.36

pmol/l

0.16

271

2364

Other predominantly sexually transmitted diseases, not elsewhere classified

277

2442

1.14

1.32

1.3

1.5

68.46

100.62

pmol/l

2.00

267

2381

Schizophrenia or delusion

246

2808

0.87

1.32

1.5

115.97

127.98

pmol/l

0.33

238

2736

Schizophrenia, schizotypal and delusional disorders

247

2818

0.87

1.31

1.5

1.4

117.33

127.75

pmol/l

0.27

239

2746

Inflammatory bowel disease treatment related agents

1427

7539

1.06

1.31

1.4

135.51

120.33

pmol/l

0.49

1395

7344

COPD/asthma/ILD related infections

1415

6689

1.06

1.31

1.5

1.4

112.71

125.94

pmol/l

0.72

1375

6534

COPD/asthma related infections

1415

6689

1.06

1.31

1.5

1.4

112.71

125.94

pmol/l

0.72

1375

6534

Acute bronchitis

393

3468

1.11

1.30

1.5

1.4

147.05

153.01

pmol/l

0.05

381

3371

Acute appendicitis, no complications

646

5929

1.09

1.29

1.4

101.52

113.61

pmol/l

0.38

627

5795

IBD patients in KELA-register

228

1988

1.15

1.28

1.4

61.17

128.55

pmol/l

6.36

222

1935

Schizophrenia or delusion, excluding more controls

246

2773

0.88

1.28

1.5

1.4

115.97

122.08

pmol/l

0.15

238

2705

Somatoform disorder

207

1794

1.16

1.28

1.4

173.70

134.31

pmol/l

0.36

199

1748

Striking against or struck by other objects

262

2306

1.14

1.26

1.3

1.4

83.05

120.64

pmol/l

1.90

253

2241

Other diseases of hard tissues of teeth

667

3178

1.09

1.26

1.5

1.4

139.93

150.41

pmol/l

0.21

647

3111

Diseases of external ear

320

2855

1.12

1.26

1.4

132.27

149.38

pmol/l

0.29

304

2780

Actinomycosis

2.46

1.25

3.0

1.4

83.50

100.14

pmol/l

—

Inflammatory bowel disease, strict (require KELA)

228

1992

1.15

1.25

1.4

1.5

61.17

121.94

pmol/l

5.85

222

1941

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.43

1.25

1.7

1.4

92.92

68.86

pmol/l

—

Appendicitis, broad definition

872

7367

1.07

1.24

1.4

95.63

123.13

pmol/l

1.69

846

7196

Other and unspecified nonorganic psychotic disorders

144

1700

0.84

1.23

1.5

88.89

123.63

pmol/l

1.16

138

1657

Migraine without aura and triptan purchases

268

2372

1.13

1.23

1.4

1.5

59.01

99.16

pmol/l

3.17

258

2322

Subjective visual disturbances

292

2597

1.13

1.23

1.3

1.4

108.47

154.26

pmol/l

1.24

280

2522

Anuria and oliguria

2.20

1.22

1.1

1.5

119.38

80.96

pmol/l

—

Mycoses

260

2297

1.13

1.22

1.5

1.4

139.15

150.39

pmol/l

0.13

251

2232

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

431

3918

1.10

1.22

1.5

1.4

156.55

138.73

pmol/l

0.16

421

3818

Non-allergic asthma (mode), excluding more controls

157

1820

0.85

1.22

1.5

1.4

75.44

135.46

pmol/l

4.45

151

1778

Sulfasalazine

269

3030

0.89

1.20

1.4

191.25

129.83

pmol/l

0.54

256

2950

Candidiasis

158

1349

1.18

1.20

1.5

150.96

154.47

pmol/l

0.03

152

1315

Haemorrhage in early pregnancy

526

4703

1.09

1.20

1.4

91.01

110.66

pmol/l

0.94

512

4598

Nonorganic sleeping disorders, excluding more controls

229

2010

1.14

1.19

1.4

1.5

79.50

116.62

pmol/l

1.70

221

1958

Non-allergic asthma (mode)

157

1816

0.85

1.19

1.5

1.4

75.44

137.64

pmol/l

4.70

151

1772

Other obstetric conditions, not elsewhere classified

546

3777

0.92

1.19

1.4

50.36

68.21

pmol/l

3.05

532

3674

Used for control exclusion in common control thyroid runs

1241

5918

1.06

1.18

1.4

132.98

113.44

pmol/l

0.56

1209

5765

Malignant cancer of tonsil and base of tongue, including Hilmo

1.89

1.18

1.2

1.4

439.25

63.13

pmol/l

0.77

LSIL lesion of the cervix uteri, vagina or vulva

250

2213

1.13

1.17

1.3

1.5

69.29

109.53

pmol/l

2.73

245

2164

2.56

1.16

1.6

75.40

49.33

pmol/l

—

Intestinal infectious diseases

1124

8050

1.06

1.15

1.4

140.24

122.03

pmol/l

0.50

1078

7855

Deep bite

801

0.80

1.14

1.4

1.5

90.89

142.02

pmol/l

0.54

781

Open wound of wrist and hand

364

3217

1.11

1.14

1.5

81.25

110.30

pmol/l

1.98

352

3127

Benign neoplasm of bone and articular cartilage

715

1.24

1.14

1.5

75.69

167.88

pmol/l

2.45

704

Other and unspecified abdominal hernia

292

1.38

1.14

1.3

1.4

250.15

222.87

pmol/l

0.07

286

Disorders of synovium and tendon

684

5569

1.08

1.14

1.4

111.35

132.39

pmol/l

0.92

663

5440

Gonarthrosis, primary, with knee surgery

562

4126

1.09

1.14

1.4

222.71

165.91

pmol/l

0.78

550

4025

Carpal tunnel syndrome

794

6542

1.07

1.13

1.5

1.4

149.53

139.47

pmol/l

0.15

777

6391

Bitten or struck by other mammals

137

1163

1.18

1.13

1.4

86.55

131.20

pmol/l

0.87

128

1133

Spirochaetal infections, other/unspecified

716

1.24

1.13

1.4

1.5

98.80

194.16

pmol/l

2.13

702

Necrosis of pulp, including avohilmo

676

6273

1.08

1.12

1.4

116.94

116.92

pmol/l

0.00

654

6133

Other specified/unspecified arthritis

253

2844

0.89

1.12

1.4

121.01

145.06

pmol/l

0.57

244

2767

Other and unspecified dermatitis

617

5723

1.08

1.11

1.4

113.97

138.29

pmol/l

1.12

594

5588

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

412

0.70

1.11

1.4

72.31

112.15

pmol/l

0.67

398

Endovascular or surgical operations to intracerebral aneurysms

515

0.73

1.10

1.2

1.5

91.53

238.41

pmol/l

2.77

504

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

534

3677

0.92

1.10

1.4

49.89

61.87

pmol/l

2.64

519

3575

Urticaria

390

3550

1.10

1.4

1.5

108.38

121.69

pmol/l

0.32

375

3458

Other and unspecified urticaria

247

2194

1.13

1.10

1.4

106.67

131.06

pmol/l

0.48

239

2135

Diseases of oral cavity, salivary glands and jaws

667

3183

1.08

1.10

1.5

1.4

160.91

150.48

pmol/l

0.15

650

3116

351

3499

0.91

1.09

1.5

1.4

182.48

122.04

pmol/l

0.84

341

3408

Generalized anxiety disorder

204

1793

1.14

1.08

1.4

1.5

74.87

104.94

pmol/l

1.01

198

1741

Maternal care for known or suspected fetal abnormality and damage

240

2320

0.89

1.07

1.4

55.12

71.60

pmol/l

1.77

229

2264

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

295

3261

0.90

1.06

1.3

1.4

72.41

100.24

pmol/l

2.50

288

3177

Type1 diabetes, definitions combined, early onset

451

0.73

1.05

1.5

1.4

71.55

54.81

pmol/l

0.45

438

All dysplastic lesions of the vagina

350

1.33

1.04

1.2

1.5

148.04

189.18

pmol/l

0.21

343

Allergic conjunctivitis

763

7923

0.94

1.04

1.4

94.98

125.59

pmol/l

2.12

749

7715

Acute appendicitis

809

7101

1.07

1.03

1.4

94.91

122.19

pmol/l

1.54

787

6934

Left ventricular outflow tract obstruction, narrow definition

221

1.41

1.02

1.3

1.4

75.64

152.15

pmol/l

0.76

215

Benign neoplasm: Sigmoid colon

146

1258

1.16

1.02

1.3

1.5

150.10

207.38

pmol/l

0.76

140

1225

Bacterial Sepsis

357

2774

1.10

1.02

1.6

1.4

243.85

176.57

pmol/l

1.29

345

2700

Fall on same level

1325

7600

0.95

1.02

1.4

109.15

123.59

pmol/l

0.88

1282

7416

Use of glatiramer acetate

201

0.59

1.01

1.2

1.4

82.32

115.80

pmol/l

0.25

195

Superficial injury of head

224

1989

1.13

1.01

1.4

126.96

170.34

pmol/l

0.83

218

1932

Severe visual impairment, binocular

2.04

1.01

1.4

1.5

110.29

89.28

pmol/l

—

Complications of other internal prosthetic devices, implants and grafts

265

1.37

1.00

2.0

1.4

109.58

212.84

pmol/l

1.19

260

Seropositive rheumatoid arthritis

260

2883

0.90

1.00

1.5

1.4

230.80

161.46

pmol/l

0.59

255

2814

Gonarthrosis

645

3940

0.93

1.00

1.4

170.84

139.21

pmol/l

0.54

628

3854

Temporomandibular joint disorders, including avohilmo

669

6169

1.07

0.99

1.4

68.64

112.65

pmol/l

7.22

648

6009

Post-traumatic stress disorder

116

985

1.18

0.99

1.4

65.61

89.48

pmol/l

0.61

108

960

Panic disorder

187

1647

1.14

0.98

1.4

1.5

67.11

110.92

pmol/l

2.35

181

1602

Malignant neoplasm of base of tongue, including Hilmo

2.19

0.98

1.4

1.3

77.40

59.26

pmol/l

—

Other disorders of bone density and structure

215

1.41

0.98

1.4

66.15

227.46

pmol/l

1.33

209

Dermatitis

719

6722

1.07

0.97

1.4

115.54

138.85

pmol/l

1.05

694

6555

Epidural haemorrhage

1.96

0.97

1.6

1.3

114.29

353.57

pmol/l

—

Autoimmune diseases

1324

6412

1.05

0.97

1.5

1.4

135.73

115.16

pmol/l

0.61

1284

6247

Bronchiectasis

582

0.77

0.97

1.9

1.4

111.71

214.85

pmol/l

2.32

566

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.96

0.0

1.6

—

88.43

—

Pervasive developmental disorders excl. Autism + Asperger

1.79

0.96

1.4

1.3

193.56

43.22

pmol/l

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.95

0.0

1.4

—

267.81

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

714

1.21

0.95

1.5

123.28

202.69

pmol/l

0.75

699

Adrenocortical insufficiency

294

1.34

0.95

1.4

83.88

218.48

pmol/l

1.57

288

Paroxysmal tachycardia

252

1894

1.12

0.94

1.4

114.87

111.48

pmol/l

0.06

243

1851

Cysts of oral region, not elsewhere classified

373

1.29

0.94

1.6

1.5

108.56

211.42

pmol/l

0.99

366

Care involving use of rehabilitation procedures

602

5922

0.93

0.94

1.4

126.86

101.63

pmol/l

0.96

582

5798

Allergic asthma (mode), excluding more controls

303

2693

1.10

0.94

1.4

99.59

105.23

pmol/l

0.10

297

2632

Thyrotoxicosis, other and/or unspecified

270

2440

1.11

0.93

1.4

217.74

146.46

pmol/l

0.48

264

2368

Crohn disease

126

1084

1.17

0.93

1.3

1.5

69.85

145.76

pmol/l

3.31

121

1055

Short Achilles tendon (acquired)

268

0.67

0.93

1.2

1.5

69.63

121.52

pmol/l

1.79

263

Ulcerative rectosigmoiditis

625

1.22

0.93

1.4

1.5

58.81

125.67

pmol/l

2.27

613

Nonorganic sleeping disorders

229

2052

1.12

0.92

1.4

1.5

79.50

121.15

pmol/l

2.00

221

2000

Pregnancy hypertension

698

6646

0.94

0.92

1.4

76.17

109.98

pmol/l

5.48

682

6494

Diseases of the respiratory system

897

4245

1.06

0.91

1.5

1.4

160.72

120.98

pmol/l

1.24

872

4162

Femoral hernia

291

0.68

0.91

1.4

1.5

72.80

232.46

pmol/l

2.01

285

Benign paroxysmal vertigo

333

3044

1.10

0.91

1.5

1.4

133.17

174.13

pmol/l

1.19

323

2962

ILD medications

1401

7259

1.05

0.91

1.4

131.49

119.83

pmol/l

0.39

1365

7071

Medical abortion

1114

6349

0.95

0.91

1.5

1.4

120.51

129.82

pmol/l

0.28

1072

6187

Arthrosis

758

4418

0.94

0.90

1.4

138.61

130.19

pmol/l

0.14

740

4318

Postpartum hemorraghe, parous women as controls

448

3531

1.08

0.90

1.4

54.54

88.92

pmol/l

5.05

437

3448

Actinomycosis

2.11

0.90

3.0

1.4

83.50

90.76

pmol/l

—

Hereditary retinal dystrophy

102

0.49

0.90

1.2

1.4

60.60

77.78

pmol/l

—

102

Flat foot [pes planus] (acquired)

1100

0.84

0.90

1.3

1.5

97.27

167.43

pmol/l

1.86

1072

Aggressive periodontitis

152

0.59

0.89

1.6

1.4

1228.89

207.44

pmol/l

—

147

Other/unspecified enthesopathies of lower limb, excluding foot

665

1.21

0.89

1.6

1.5

233.16

164.64

pmol/l

0.16

652

Suicide or other Intentional self-harm

215

2397

0.90

0.88

1.3

1.4

80.73

122.23

pmol/l

2.74

210

2338

L04AD Calcineurin inhibitors

766

1.19

0.88

1.7

1.5

216.92

165.16

pmol/l

0.53

755

Psoriasis

223

2481

0.90

0.88

1.4

114.25

148.35

pmol/l

0.69

217

2413

Whooping cough

1.89

0.88

1.1

1.5

346.63

49.78

pmol/l

—

Malignant neoplasm of bone and articular cartilage

1.88

0.88

2.5

1.3

161.13

60.17

pmol/l

—

Allergic asthma (mode)

303

2705

1.10

0.88

1.4

99.59

106.17

pmol/l

0.12

297

2640

Atrial septal defect, secundum type

203

1.38

0.86

1.5

1.4

82.16

162.60

pmol/l

0.70

197

Diabetes, insulin treatment (Kela reimbursement)

1091

6915

0.95

0.86

1.4

174.13

129.33

pmol/l

1.66

1057

6756

Localized swelling, mass and lump of skin and subcutaneous tissue

329

3016

1.09

0.86

1.4

141.90

142.57

pmol/l

0.01

320

2932

Other acute lower respiratory infections

495

4394

1.07

0.86

1.5

1.4

131.95

139.16

pmol/l

0.09

478

4266

Hyperparathyroidism

198

1750

1.12

0.85

1.6

1.4

212.33

222.87

pmol/l

0.07

190

1698

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

742

7629

0.94

0.85

1.4

93.80

126.96

pmol/l

2.38

729

7427

Diseases of salivary glands

374

3451

1.09

0.85

1.4

119.59

142.47

pmol/l

0.62

362

3360

Chronic tubulo-interstitial nephritis

300

1.31

0.84

1.4

252.01

176.32

pmol/l

0.44

294

Other keratitis

111

955

1.17

0.84

1.5

88.68

141.87

pmol/l

1.53

111

930

Haemorrhage from respiratory passages

272

2229

1.10

0.84

1.5

1.4

269.95

182.11

pmol/l

0.61

262

2175

Coxarthrosis, primary, with hip surgery

355

3605

0.92

0.84

1.4

1.5

147.85

191.81

pmol/l

1.46

345

3513

Anogenital herpesviral [herpes simplex] infection

679

1.20

0.84

1.5

1.4

67.39

103.25

pmol/l

0.70

662

SLE (Finngen)

372

1.27

0.83

1.5

157.87

170.74

pmol/l

0.08

367

Malignant neoplasm of head and neck

222

1.35

0.83

1.4

233.47

63.36

pmol/l

0.93

213

Abscess of Bartholin gland

328

1.29

0.83

1.6

1.4

83.69

127.99

pmol/l

0.53

321

Malignant neoplasm of oropharynx

1.75

0.82

1.0

1.4

640.25

66.43

pmol/l

—

Hyperfunction of pituitary gland

500

0.78

0.82

1.3

1.4

52.08

135.71

pmol/l

1.79

488

Bleeding

734

5524

0.94

0.82

1.6

1.4

199.19

144.19

pmol/l

1.12

709

5391

Periodontitis

1030

7224

0.95

0.82

1.4

150.56

132.47

pmol/l

0.45

998

7061

Single delivery by caesarean section

316

1978

0.91

0.82

1.4

53.49

82.76

pmol/l

3.25

306

1927

Adhesive capsulitis of shoulder

180

1605

1.12

0.82

1.4

156.37

158.79

pmol/l

0.02

173

1562

Other arthritis (FG)

295

3221

0.91

0.82

1.4

141.57

136.27

pmol/l

0.08

286

3139

Exposure to unspecified factor

1097

8261

0.95

0.81

1.4

106.89

127.73

pmol/l

1.12

1067

8048

Impaction of intestines

1.72

0.81

1.1

1.4

109.13

76.68

pmol/l

—

Gilbert syndrome

1.72

0.81

1.5

1.4

78.38

283.03

pmol/l

—

Residual foreign body in soft tissue

318

0.72

0.81

1.7

1.5

54.35

141.06

pmol/l

1.90

313

Dental caries, including avohilmo

856

4150

1.06

0.81

1.5

1.4

155.35

138.03

pmol/l

0.33

833

4044

Osteoporosis

293

2506

1.09

0.81

1.5

178.48

212.52

pmol/l

0.76

282

2441

Spirochaetal infections, other/unspecified

331

3047

1.09

0.81

1.4

102.21

155.01

pmol/l

2.24

324

2970

Lyme disease

328

3019

1.09

0.80

1.4

102.60

155.85

pmol/l

2.23

321

2944

Other/unspecified seropositive rheumatoid arthritis

254

2788

0.91

0.80

1.5

1.4

233.83

164.45

pmol/l

0.57

249

2716

Other spirochaetal diseases

335

3088

1.09

0.79

1.4

101.54

156.77

pmol/l

2.43

328

3010

Chronic periodontitis, including avohilmo

1028

7217

0.95

0.79

1.4

140.64

134.00

pmol/l

0.16

996

7054

Rotator cuff syndrome

602

4588

0.94

0.79

1.4

131.73

148.98

pmol/l

0.54

586

4489

Pain in thoracic spine

179

1601

1.12

0.78

1.6

1.4

68.59

151.45

pmol/l

6.87

174

1554

Other/unspecified disorders of vestibular function

304

0.72

0.78

1.1

1.5

163.00

249.98

pmol/l

0.48

297

Spondylosis

565

4326

1.07

0.78

1.4

146.88

155.33

pmol/l

0.11

551

4226

Systemic lupus erythematosus

376

1.26

0.78

1.5

1.4

157.87

188.75

pmol/l

0.19

369

Chondrocostal junction syndrome [Tietze]

358

1.27

0.78

1.4

70.71

211.38

pmol/l

2.18

352

Labour and delivery complicated by fetal stress [distress]

405

2853

0.93

0.77

1.4

58.35

64.59

pmol/l

0.32

395

2779

Alcohol use disorder, Swedish definition

324

3220

0.92

0.77

1.5

1.4

166.06

124.67

pmol/l

0.67

314

3136

Anterior Iridocyclitis

193

1737

1.11

0.76

1.4

281.52

146.48

pmol/l

1.10

186

1693

Fibroblastic disorders

191

1718

1.11

0.76

1.4

175.01

157.45

pmol/l

0.17

184

1672

Pustulosis palmaris et plantaris

415

0.77

0.76

1.4

1.5

112.25

204.43

pmol/l

1.01

409

Seropositive rheumatoid arthritis, strict definition

135

1528

0.88

0.75

1.4

280.05

164.25

pmol/l

0.55

130

1493

Atopic dermatitis

792

6164

1.05

0.75

1.4

88.25

112.24

pmol/l

0.94

770

6014

Supervision of high-risk pregnancy

379

2114

1.08

0.75

1.5

1.4

72.73

82.78

pmol/l

0.29

371

2067

Other disorders of choroid

1.58

0.75

1.2

1.4

134.42

164.44

pmol/l

0.10

Etanercept

636

0.81

0.75

1.5

71.23

169.96

pmol/l

2.36

627

Morphin

1.58

0.75

1.5

1.6

209.22

145.67

pmol/l

0.36

Chronic rhinitis, nasopharyngitis and pharyngitis

382

3550

1.08

0.75

1.5

1.4

103.64

135.29

pmol/l

1.11

370

3467

Superficial injury of hip and thigh

120

1050

1.14

0.75

1.3

1.5

119.25

180.71

pmol/l

0.97

113

1020

Other infectious diseases

459

1.22

0.74

1.6

1.5

319.81

196.29

pmol/l

0.31

452

Hydrocephalus

459

0.78

0.74

1.5

336.69

229.09

pmol/l

0.25

451

Asthma mixed form (mode), excluding more controls

436

0.78

0.74

1.6

1.4

62.99

140.69

pmol/l

1.40

426

Herpesviral [herpes simplex] infections

279

3034

0.92

0.73

1.4

99.95

122.38

pmol/l

0.61

272

2955

Suppurative and unspecified otitis media

392

3233

1.08

0.73

1.4

1.5

79.94

101.96

pmol/l

0.88

369

3145

Malignant neoplasm of nasal cavity and middle ear

2.03

0.73

1.2

1.3

52.80

57.80

pmol/l

—

Erysipelas

623

5030

0.94

0.73

1.5

1.4

177.15

134.67

pmol/l

0.88

607

4909

Shoulder lesions

889

5132

1.05

0.72

1.5

1.4

130.71

139.89

pmol/l

0.30

869

5013

Viral haemorrhagic fevers, not elsewhere classified/unspecified

479

1.21

0.72

1.4

1.5

93.66

194.92

pmol/l

1.54

472

Any mental disorder

1371

6601

1.04

0.72

1.4

137.22

125.26

pmol/l

0.32

1334

6442

Disorders of porphyrin and bilirubin metabolism

1.63

0.72

2.0

1.4

71.09

227.19

pmol/l

0.51

Hypotension

102

885

1.15

0.72

1.3

1.5

175.96

212.51

pmol/l

0.38

853

Asthma mixed form (mode)

434

0.78

0.72

1.6

1.4

62.99

141.43

pmol/l

1.40

423

Other spirochaetal diseases

329

3048

1.08

0.71

1.4

102.55

154.99

pmol/l

2.20

322

2971

Internal derangement of knee

396

3676

1.07

0.71

1.4

1.5

112.23

131.20

pmol/l

0.54

380

3589

Other fibroblastic disorders

1.96

0.71

1.4

1.7

55.60

71.23

pmol/l

—

Nondiabetic hypoglycaemic coma

1.96

0.71

1.0

1.3

310.40

60.29

pmol/l

—

Artrosis, including avohilmo

912

5229

0.95

0.71

1.4

136.94

123.64

pmol/l

0.26

893

5113

Long labour

398

3647

0.93

0.71

1.4

91.12

94.62

pmol/l

0.06

393

3562

Malignant neoplasm of nasal cavity and sinuses

1.94

0.71

1.2

1.3

52.80

56.65

pmol/l

—

Cardiomyopathies, Secondary/extrinsic

1.94

0.71

2.4

1.4

103.80

96.32

pmol/l

—

Polyarthropathies

718

4937

0.95

0.70

1.4

172.45

121.82

pmol/l

1.33

702

4819

Stomatitis and related lesions

203

1843

1.10

0.70

1.5

1.4

100.23

141.42

pmol/l

1.33

197

1790

Malignant neoplasm of tonsil

1.72

0.70

1.0

1.3

697.71

66.37

pmol/l

—

Adverse effects, not elsewhere classified

235

2150

1.10

0.69

1.3

1.4

87.39

129.13

pmol/l

1.74

228

2096

Acute upper respiratory infections of multiple and unspecified sites

924

6545

1.05

0.69

1.5

1.4

110.80

124.18

pmol/l

0.48

891

6389

Erosion of teeth , including avohilmo

275

2535

1.09

0.68

1.4

1.5

75.56

114.22

pmol/l

1.88

267

2467

Malignant neoplasm of tongue

1.53

0.68

1.6

1.3

77.33

59.85

pmol/l

—

Extrapyramidal and movement disorders

300

3239

0.92

0.68

1.3

1.4

108.57

173.34

pmol/l

3.69

292

3157

Symptoms and signs involving speech and voice

323

3477

0.93

0.68

1.4

181.53

148.37

pmol/l

0.35

312

3385

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1054

6618

0.96

0.68

1.4

163.79

123.97

pmol/l

1.44

1021

6466

Disturbances of skin sensation

345

3212

1.08

0.67

1.4

104.52

119.19

pmol/l

0.30

339

3129

Other disorders of white blood cells

366

1.23

0.66

1.6

1.5

101.27

192.72

pmol/l

1.16

358

Sequelae of burns, corrosions and frostbite

1.81

0.66

1.6

1.2

158.40

97.96

pmol/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

162

1459

1.11

0.66

1.4

1.5

75.05

118.34

pmol/l

1.65

157

1423

Chronic Coagulation defects

241

1.30

0.66

1.3

1.4

124.74

112.40

pmol/l

0.07

235

Ductal carcinoma of pancreas

1.80

0.66

2.8

1.3

75.00

62.04

pmol/l

—

Psychiatric diseases

1217

5862

1.04

0.66

1.4

123.33

131.38

pmol/l

0.25

1177

5729

Tinnitus

228

2090

1.09

0.66

1.3

1.4

104.29

170.87

pmol/l

2.54

222

2038

Other systemic involvement of connective tissue

330

3073

1.08

0.65

1.5

1.4

114.76

163.82

pmol/l

2.05

324

2986

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

791

7195

0.95

0.65

1.4

81.06

114.85

pmol/l

5.57

773

7028

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

254

2753

0.92

0.65

1.5

1.4

233.83

164.21

pmol/l

0.58

249

2681

Diabetic retinopathy

201

1375

0.91

0.64

1.4

1.5

193.60

183.62

pmol/l

0.11

193

1335

ILD, hospital admissions 3, with pneumonia sepsis

427

0.79

0.64

1.8

1.5

232.47

281.72

pmol/l

0.21

418

Pregnancy, childbirth and the puerperium

452

2511

0.94

0.64

1.4

1.5

172.19

158.69

pmol/l

0.13

438

2434

Specific personality disorders

236

2565

0.92

0.64

1.5

118.26

105.86

pmol/l

0.13

230

2501

Diseases of the musculoskeletal system and connective tissue

702

3347

1.05

0.64

1.4

148.34

114.54

pmol/l

0.58

685

3262

Behavioural disorders, excluding more controls

126

0.63

0.64

1.1

1.4

41.38

60.27

pmol/l

—

120

Contact with other hot fluids

212

0.70

0.63

1.4

1.3

43.20

121.76

pmol/l

0.93

207

Asthma-related pneumonia

287

3087

0.93

0.63

1.6

1.4

246.80

158.61

pmol/l

1.06

279

3000

Failed induction of labour

869

1.14

0.63

1.3

1.5

64.66

58.89

pmol/l

0.10

840

Other and unspecified visual disturbances

103

906

1.14

0.63

1.5

91.72

176.94

pmol/l

2.36

103

886

Diseases of the ear and mastoid process

1476

7160

1.04

0.63

1.4

104.78

127.43

pmol/l

1.56

1425

6995

Pustular psoriasis

436

0.80

0.63

1.3

1.5

110.17

206.33

pmol/l

1.16

429

Seropositive rheumatoid arthritis, wide

260

2811

0.92

0.63

1.5

1.4

230.80

164.46

pmol/l

0.56

255

2739

Mouth breathing

309

2871

1.08

0.63

1.4

91.44

138.65

pmol/l

2.95

300

2794

Malignant neoplasm of rectosigmoid junction

1.64

0.62

1.4

654.80

64.59

pmol/l

—

Schizoaffective disorder

664

0.84

0.62

1.5

110.16

152.40

pmol/l

0.50

654

Other specified and unspecified disorders of choroid

1.69

0.62

1.2

1.4

40.80

79.38

pmol/l

—

Obstetric embolism

0.00

0.62

0.0

1.3

—

73.35

—

Other diseases of lip and oral mucosa

459

4333

1.06

0.61

1.4

105.84

146.93

pmol/l

1.94

446

4229

Other specified and unspecified disorders of lens

1.58

0.61

1.6

1.2

128.13

490.75

pmol/l

—

Myocardial infarction, with ST-elevation

522

0.82

0.61

1.5

153.59

246.51

pmol/l

1.12

506

Fitting and adjustment of external prosthetic device

0.00

0.60

0.0

1.2

—

84.02

—

Glaucoma secondary to drugs

0.00

0.60

0.0

1.5

—

557.74

—

Superficial injury of wrist and hand

204

1870

1.09

0.60

1.4

1.5

125.68

123.11

pmol/l

0.02

199

1819

Recurrent aphthous stomatitis , including avohilmo

145

1307

1.11

0.60

1.5

101.52

159.37

pmol/l

1.42

140

1272

Plasmodium falciparum malaria

0.00

0.60

0.0

1.5

—

56.50

—

Asthma-related pneumonia or sepsis

289

3098

0.93

0.60

1.6

1.4

245.37

159.16

pmol/l

1.04

281

3011

Asthma, hospital admissions 3, pneumonia

289

3098

0.93

0.60

1.6

1.4

245.37

159.16

pmol/l

1.04

281

3011

Heart failure and bmi 25plus

201

1481

0.92

0.59

1.5

236.16

185.96

pmol/l

0.43

196

1440

Perineal laceration during delivery

263

2369

0.93

0.59

1.3

1.5

62.67

84.36

pmol/l

0.72

255

2303

Maternal care related to the fetus and amniotic cavity and possible delivery problems

768

4709

0.96

0.59

1.4

72.22

112.02

pmol/l

4.03

751

4601

Congenital malformations of nose

0.00

0.59

0.0

1.3

—

58.03

—

Other and unspecified effects of external causes

307

2865

1.07

0.59

1.4

1.5

85.58

120.75

pmol/l

1.87

296

2788

Cleft lip

0.00

0.59

0.0

1.3

—

49.55

—

Other cestode infections

0.00

0.59

0.0

1.4

—

104.03

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.59

0.0

1.3

—

67.91

—

Other maternal disorders predominantly related to pregnancy

1022

6653

0.96

0.59

1.5

1.4

95.56

116.69

pmol/l

1.19

1000

6498

Malignant neoplasm of other and unspecified parts of tongue

1.52

0.58

1.6

1.4

78.25

61.64

pmol/l

—

Malignant cancer of tonsil and base of tongue

1.51

0.58

1.0

1.4

619.25

64.55

pmol/l

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.74

0.58

2.0

1.2

84.67

358.55

pmol/l

—

Purulent endophthalmitis

1.73

0.58

1.5

1.4

295.00

103.19

pmol/l

—

Macular hole

420

0.81

0.58

1.6

1.5

242.26

274.47

pmol/l

0.08

410

499

4693

1.06

0.58

1.5

1.4

135.69

124.66

pmol/l

0.17

483

4562

Mental and behavioural disorders due to alcohol

303

3118

0.93

0.58

1.4

176.68

119.80

pmol/l

0.65

297

3035

Disease of hard tissues of teeth, NOS

634

3158

1.05

0.58

1.4

120.03

150.18

pmol/l

0.96

614

3095

Melanocytic naevi of lower limb, including hip

401

1.20

0.57

1.4

1.5

80.27

174.50

pmol/l

1.23

394

Epilepsy

238

2562

0.92

0.57

1.4

136.52

155.16

pmol/l

0.32

233

2494

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

275

0.76

0.57

1.3

1.4

50.00

190.24

pmol/l

1.63

269

Chronic myeloid leukaemia, including Hilmo

1.68

0.57

1.3

1.4

68.52

63.97

pmol/l

—

L04AC Interleukin inhibitors

466

1.18

0.57

1.3

1.5

69.99

163.84

pmol/l

1.58

458

Other bacterial intestinal infections

213

1964

1.09

0.56

1.4

147.65

155.13

pmol/l

0.09

207

1912

Asthma, hospital admissions , main diagnosis only

980

8326

1.04

0.56

1.5

1.4

113.40

127.23

pmol/l

0.46

958

8106

Asthma and opportunity respiratory infection

330

0.78

0.56

1.7

1.5

90.50

206.05

pmol/l

2.01

323

Hypertrophy of breast in women and men

297

2778

1.07

0.55

1.3

1.5

98.38

129.35

pmol/l

0.92

287

2710

Other retinal disorders

523

4283

0.95

0.55

1.4

192.02

162.67

pmol/l

0.51

502

4172

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

1.59

0.54

1.2

1.3

54.17

63.89

pmol/l

—

SLE, strict definition

358

1.21

0.54

1.4

1.5

168.30

179.83

pmol/l

0.06

351

SLE, ICD10

358

1.21

0.54

1.4

1.5

168.30

179.83

pmol/l

0.06

351

Malignant neoplasm of oesophagus

1.58

0.54

2.3

1.4

203.50

73.56

pmol/l

—

Disorders of vestibular function (Vertigo)

528

4943

1.05

0.54

1.5

1.4

128.58

161.59

pmol/l

1.47

516

4814

Progressive vascular leukoencephalopathy

182

0.71

0.54

1.3

1.4

128.23

365.14

pmol/l

1.82

177

Superficial injury of thorax

1037

0.89

0.54

1.4

1.5

79.78

167.08

pmol/l

3.58

1013

Postpartum haemorrhage due to retained placenta

197

1817

1.09

0.54

1.4

51.65

81.93

pmol/l

2.59

192

1773

Other endophthalmitis

1.56

0.53

1.3

67.38

357.65

pmol/l

—

Gonarthrosis,primary

875

5599

0.96

0.53

1.4

213.78

143.33

pmol/l

1.48

855

5474

Iridocyclitis

215

1991

1.08

0.53

1.4

265.95

148.05

pmol/l

1.04

205

1939

Arthropathies

1142

5591

1.04

0.53

1.4

111.51

112.89

pmol/l

0.03

1109

5446

Eclampsia

1.53

0.52

1.2

1.5

57.83

46.12

pmol/l

—

Other (seronegative) rheumatoid arthritis, wide

173

1882

0.92

0.52

1.5

1.4

176.72

174.73

pmol/l

0.02

167

1836

Pregnancy examination and test

289

1679

1.07

0.52

1.3

1.4

51.84

69.16

pmol/l

1.87

281

1635

Hypertrophy of breast

296

2777

1.07

0.52

1.3

1.5

98.47

129.37

pmol/l

0.91

286

2709

Disorders of parathyroid gland

223

2045

1.08

0.52

1.6

1.4

198.42

211.00

pmol/l

0.09

213

1987

Foreign body on external eye

489

1.17

0.52

1.4

90.63

144.98

pmol/l

0.71

478

Chronic hepatitis, not elsewhere classified

287

1.23

0.51

1.4

1.5

122.35

216.31

pmol/l

0.81

282

Voice disturbances

273

2916

0.93

0.51

1.4

199.89

143.44

pmol/l

0.57

263

2837

Systemic lupus erythematosus, unspecified

315

1.21

0.51

1.4

1.5

142.34

191.38

pmol/l

0.29

308

Hernia

1075

6966

1.03

0.51

1.5

1.4

159.26

131.48

pmol/l

1.11

1053

6797

Personality disorders

276

2944

0.94

0.50

1.5

110.97

106.94

pmol/l

0.05

269

2868

Mental and behavioural disorders due to psychoactive substance use

424

4138

0.95

0.50

1.5

1.4

156.28

118.44

pmol/l

0.58

416

4031

Other peripheral vertigo

801

1.13

0.50

1.6

1.4

114.31

203.13

pmol/l

1.71

785

Chronic sinusitis

511

4870

1.05

0.50

1.3

1.4

111.04

134.91

pmol/l

0.67

499

4766

Supervision of normal pregnancy

354

2142

0.94

0.50

1.4

46.47

80.21

pmol/l

4.46

348

2090

Mental and behavioural disorders due to opioids

224

0.76

0.50

1.7

1.3

74.18

111.55

pmol/l

0.36

219

False labour

563

3354

1.05

0.49

1.4

59.96

79.11

pmol/l

1.89

545

3276

Use of fingolimod

110

0.63

0.49

1.4

34.83

54.13

pmol/l

—

105

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

140

1240

1.10

0.49

1.3

1.5

129.16

143.88

pmol/l

0.22

135

1206

Pre-eclampsia or poor fetal growth

503

5248

0.95

0.49

1.4

80.23

101.99

pmol/l

1.94

497

5112

Contusion of toe(s) without damage to nail

235

1.24

0.48

1.5

1.4

145.97

105.33

pmol/l

0.16

229

Malignant neoplasm of tonsil, including Hilmo

1.49

0.47

1.0

1.4

697.71

66.26

pmol/l

—

Pacemaker

184

1632

1.08

0.47

1.4

1.5

230.63

230.61

pmol/l

0.00

176

1580

Lumbar disc prolapse

740

5464

1.04

0.47

1.4

117.02

134.71

pmol/l

0.73

718

5332

Rheumatoid arthritis

351

3323

0.95

0.47

1.5

219.84

150.00

pmol/l

0.83

342

3240

Dental operations

662

3265

1.04

0.46

1.5

1.4

150.75

156.72

pmol/l

0.08

648

3190

Viral warts

209

1951

1.07

0.44

1.4

74.54

128.57

pmol/l

3.63

201

1896

Diabetes mellitus in pregnancy

584

3894

0.96

0.44

1.5

1.4

74.02

75.28

pmol/l

0.04

567

3813

Type of accident

261

2456

1.06

0.44

1.4

152.04

142.90

pmol/l

0.12

253

2387

Routine general health check-up of defined subpopulation

220

1.23

0.44

1.4

86.96

113.04

pmol/l

0.22

215

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

527

4907

1.04

0.44

1.4

97.02

136.34

pmol/l

2.99

511

4803

Cardiac arrest

244

0.80

0.43

1.8

1.4

156.87

218.77

pmol/l

0.37

237

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

1.62

0.43

1.2

1.3

52.80

60.97

pmol/l

—

Fibrosarcoma, including Hilmo

1.62

0.43

1.6

1.4

162.40

61.66

pmol/l

—

Fracture at wrist and hand level

279

2628

1.06

0.43

1.4

144.49

135.83

pmol/l

0.09

271

2554

Arthropod-borne viral fevers and viral haemorrhagic fevers

125

1362

0.92

0.43

1.3

1.5

116.67

157.35

pmol/l

0.94

125

1329

Migraine with aura and triptan purchases

236

2218

1.07

0.42

1.4

1.5

71.52

102.34

pmol/l

1.65

226

2166

Malignant neoplasm of oropharynx, including Hilmo

1.43

0.42

1.0

1.4

640.25

65.42

pmol/l

—

Mantle cell lymphoma, including Hilmo

1.57

0.42

1.4

178.20

70.92

pmol/l

—

Disorders of vitreous body and globe

533

4914

1.04

0.42

1.5

1.4

133.95

166.81

pmol/l

1.10

521

4793

Disorders of adult personality and behaviour

293

3095

0.95

0.42

1.5

107.35

101.92

pmol/l

0.07

286

3010

General autosomal fish scale disease

0.00

0.42

0.0

1.5

—

65.00

—

Implicit bacterial Sepsis

284

2378

1.06

0.42

1.6

1.4

256.32

188.00

pmol/l

1.15

275

2316

Migraine with aura

369

3514

1.05

0.42

1.4

69.32

115.13

pmol/l

5.33

357

3429

Medullary cystic kidney disease, nephronophthisis

0.00

0.42

0.0

1.2

—

67.36

—

Open wound of hip and thigh

176

1.25

0.42

1.5

1.4

63.11

130.61

pmol/l

0.57

170

Kidney diseases associated to Fabry's disease

0.00

0.42

0.0

1.8

—

739.84

—

L04AA Selective immunosuppressants

206

2199

0.94

0.42

1.6

1.4

135.50

142.10

pmol/l

0.12

198

2141

Congenital malformations of nose

0.00

0.41

0.0

1.3

—

60.79

—

Congenital myopathies

0.00

0.41

0.0

1.7

—

48.54

—

Pityriasis rubra pilaris

0.00

0.41

0.0

1.3

—

62.17

—

Sphingolipidosis, other/unspecified

0.00

0.41

0.0

1.8

—

696.73

—

Gangrene, not elsewhere classified

1.52

0.41

2.0

1.4

64.40

369.56

pmol/l

—

Injury of blood vessels at neck level

0.00

0.41

0.0

1.6

—

103.24

—

Congenital aortic valve stenosis

0.00

0.41

0.0

1.6

—

50.64

—

Injuries to the knee and lower leg

1452

7858

1.03

0.41

1.4

130.33

124.72

pmol/l

0.16

1396

7674

Molar incisor enamel hypoplasia

209

0.78

0.41

1.5

1.4

210.53

53.78

pmol/l

0.72

198

Unspecified organic or symptomatic mental disorder

0.00

0.41

0.0

1.3

—

89.86

—

Abnormality of white blood cells, not elsewhere classified

1.37

0.41

1.6

1.4

1761.88

238.58

pmol/l

—

Glomerulonephritis

595

1.13

0.41

1.5

211.91

197.79

pmol/l

0.09

586

Isolated patent ductus arteriosus

0.00

0.41

0.0

1.5

—

55.29

—

Injury of blood vessels at hip and thigh level

0.00

0.41

0.0

1.3

—

95.18

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.41

0.0

1.4

—

51.39

—

Other and unspecified tonsillitis

294

2608

0.95

0.41

1.4

1.5

58.44

86.94

pmol/l

2.28

279

2543

Malignant neoplasm of tongue, including Hilmo

1.40

0.41

1.5

1.3

79.18

59.60

pmol/l

1.30

Anorexia (incl.atypical)

614

0.88

0.40

1.2

1.4

47.81

124.56

pmol/l

2.06

595

Erythema multiforme

186

1.24

0.40

1.3

1.4

265.61

203.40

pmol/l

0.17

181

Diaphragmatic hernia

353

3362

1.05

0.40

1.5

1.4

163.14

167.20

pmol/l

0.06

346

3270

Postpartum care and examination

227

1529

0.94

0.40

1.3

1.4

67.83

65.10

pmol/l

0.06

219

1487

Poikiloderma of Civatte

0.00

0.40

0.0

1.2

—

84.61

—

Osteogenesis imperfecta

0.00

0.40

0.0

1.3

—

58.52

—

Squamous cell neoplasms and carcinoma of cervix

1.32

0.40

1.1

1.3

240.38

57.42

pmol/l

—

Insulin, fast-acting or short human

249

2635

0.94

0.40

1.4

144.50

144.23

pmol/l

0.00

240

2560

Implicit bacterial Sepsis

322

2642

1.05

0.40

1.6

1.4

237.02

182.05

pmol/l

0.99

312

2574

Excessive earwax

486

4552

1.04

0.39

1.4

104.81

159.85

pmol/l

4.48

475

4432

Varus deformity, not elsewhere classified

105

0.66

0.39

1.1

1.4

74.86

309.98

pmol/l

—

105

Noninfective disorders of pinna

0.00

0.39

0.0

1.2

—

61.07

—

Other protozoal intestinal diseases

193

0.77

0.39

1.4

115.80

148.99

pmol/l

0.14

187

Unspecified fall

468

4424

1.04

0.39

1.4

140.06

146.70

pmol/l

0.10

456

4301

Maxillary retrognathism

137

0.73

0.39

1.1

1.3

63.60

140.66

pmol/l

—

132

Conjunctivitis

1010

8201

1.03

0.39

1.4

97.54

127.59

pmol/l

2.31

991

7980

Congenital malformations of aortic and mitral valves

187

1.23

0.39

1.3

1.4

59.65

159.18

pmol/l

0.91

182

Varicella [chickenpox]

251

1.20

0.39

1.3

1.4

63.57

129.41

pmol/l

0.75

244

Wet age-related macular degeneration

113

1006

1.09

0.38

1.4

162.06

277.10

pmol/l

2.37

106

965

Superficial injury of abdomen, lower back and pelvis

113

1229

0.92

0.38

1.3

1.5

61.98

152.76

pmol/l

5.08

106

1199

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

1.35

0.38

1.6

1.3

76.67

61.84

pmol/l

—

Diffuse brain injury

181

0.77

0.38

1.5

1.4

67.57

177.09

pmol/l

1.08

181

Glaucoma suspect

321

3369

0.95

0.38

1.4

1.5

191.28

173.74

pmol/l

0.18

308

3282

Cervicobrachial syndrome

265

2512

1.06

0.38

1.3

1.4

108.10

146.95

pmol/l

0.95

260

2444

Ehlers-Danlos syndrome

161

1.25

0.37

1.5

1.4

51.60

62.40

pmol/l

0.64

155

Presence of other functional implants

543

3627

1.04

0.37

1.4

152.83

173.89

pmol/l

0.56

523

3542

Viral pneumonia (known virus, not influenza)

125

1.28

0.37

1.3

1.4

112.43

287.26

pmol/l

0.77

125

Asthma/COPD (KELA code 203)

1147

7665

1.03

0.37

1.5

1.4

128.60

120.83

pmol/l

0.23

1119

7462

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

281

1.18

0.36

1.3

1.5

208.48

216.83

pmol/l

0.02

275

Viral pneumonia

871

0.91

0.36

1.5

175.12

175.20

pmol/l

0.00

852

Mandibular retrognathia AND surgery (BSSO)

256

0.82

0.36

1.7

1.4

79.41

134.57

pmol/l

0.49

251

Other and unspecified papulosquamous disorders

1.44

0.36

1.7

1.6

58.83

320.06

pmol/l

—

Exclusions for E4_PCOS_BROAD

157

1466

1.07

0.36

1.4

1.5

91.11

142.07

pmol/l

1.57

151

1430

Disorders of choroid and retina

740

5421

0.97

0.36

1.4

165.98

151.39

pmol/l

0.31

716

5287

Central retinal artery occlusion

0.65

0.36

1.2

1.5

178.00

338.94

pmol/l

—

Other disorders of veins

501

4801

1.04

0.35

1.4

139.42

138.38

pmol/l

0.01

490

4689

Hypoplasia of dental enamel , including avohilmo

195

0.79

0.35

1.6

1.4

222.00

54.39

pmol/l

0.72

185

Other congenital malformations of skin

338

1.16

0.35

1.3

1.5

81.09

168.66

pmol/l

1.01

331

Chronic thyroiditis

1.41

0.35

1.0

1.4

130.67

325.94

pmol/l

—

Conduct disorder

123

0.73

0.35

1.1

1.3

44.56

56.12

pmol/l

—

118

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

301

1.17

0.35

1.3

1.5

60.11

159.76

pmol/l

1.11

295

Fracture of neck

255

0.82

0.35

1.2

1.5

109.90

270.65

pmol/l

1.55

250

Concussion

562

4744

0.97

0.34

1.4

110.68

123.17

pmol/l

0.42

542

4633

Insulin, intermediate and long-acting

381

3857

0.96

0.34

1.5

179.32

151.83

pmol/l

0.58

369

3751

Right bundle-branch block

163

1.23

0.34

1.5

1.4

408.10

277.18

pmol/l

0.14

163

Mental and behavioural disorders associated with the puerperium

144

0.76

0.34

1.4

1.5

65.73

63.23

pmol/l

0.07

139

Small cell lung cancer

1.34

0.33

1.2

1.3

434.53

68.11

pmol/l

—

Small cell lung cancer, including Hilmo

1.34

0.33

1.2

1.3

434.53

68.11

pmol/l

—

Primary gonarthrosis, bilateral

492

4064

1.04

0.33

1.4

209.23

163.09

pmol/l

0.62

476

3969

Other CVD (FINNGEN)

631

1.09

0.33

1.3

1.4

161.23

158.53

pmol/l

0.02

619

Periapical abscess

430

4140

1.04

0.33

1.4

118.73

128.41

pmol/l

0.22

414

4044

Viral agents as the cause of diseases classified to other chapters

177

0.79

0.33

1.2

1.4

56.93

132.44

pmol/l

0.68

172

Other and unspecified erythematous conditions

253

0.83

0.33

1.3

1.4

66.14

262.92

pmol/l

2.18

248

Vocal cord dysfunction

168

1417

1.06

0.33

1.4

1.5

109.17

114.18

pmol/l

0.10

161

1388

Specific development disorders of scholastic skills

260

0.83

0.33

1.8

1.4

51.39

50.97

pmol/l

0.02

248

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

434

4162

1.04

0.33

1.5

1.4

96.76

109.49

pmol/l

0.36

419

4042

Benign neoplasm: Other and unspecified parts of mouth

238

1.18

0.32

1.4

1.5

60.75

210.58

pmol/l

1.52

232

Diabetic retinopathy, excluding more controls

183

1088

0.94

0.32

1.5

1.4

189.79

167.35

pmol/l

0.24

176

1054

Supplementary factors related to causes of morbidity and mortality classified elsewhere

279

2664

1.05

0.32

1.4

149.23

147.65

pmol/l

0.02

271

2591

Immunodeficiencies

398

1.13

0.32

1.6

1.5

132.31

171.14

pmol/l

0.30

391

Sleep apnoea, including avohilmo

1162

7033

1.02

0.32

1.4

117.87

135.46

pmol/l

0.68

1128

6877

Nummular dermatitis

518

0.89

0.32

1.5

172.22

215.39

pmol/l

0.16

508

Other systemic involvement of connective tissue (FG)

325

3075

1.04

0.32

1.5

1.4

115.56

150.05

pmol/l

1.29

319

2996

Other erythematous conditions

284

0.84

0.32

1.3

1.5

72.21

241.31

pmol/l

2.04

279

Other aneurysm

220

1.18

0.31

1.6

1.5

108.00

286.43

pmol/l

1.49

215

Prominent ears

0.72

0.31

1.3

39.57

46.87

pmol/l

—

Childhood asthma (age<16), excluding more controls

131

964

1.07

0.31

1.4

45.10

46.63

pmol/l

0.28

124

937

Glaucoma

522

4347

1.03

0.30

1.4

213.07

168.03

pmol/l

0.83

502

4239

Open wound of head

377

3773

0.96

0.30

1.5

1.4

146.07

152.78

pmol/l

0.08

360

3669

Paralytic strabismus

447

1.12

0.30

1.3

1.5

79.69

216.13

pmol/l

2.70

441

Fall on same level involving ice and snow

626

6081

1.03

0.30

1.4

153.22

138.04

pmol/l

0.23

603

5929

Impingement syndrome of shoulder

228

2171

1.05

0.30

1.7

1.4

91.95

150.48

pmol/l

4.19

223

2126

Viral agents as the cause of diseases classified to other chapters

207

0.82

0.30

1.4

75.12

148.88

pmol/l

0.65

202

Gingivitis and periodontal diseases

1217

6145

1.02

0.30

1.4

157.70

130.74

pmol/l

0.64

1181

5994

Villonodular synovitis (pigmented)

1.28

0.30

1.3

1.4

58.86

263.31

pmol/l

—

Injuries to the elbow and forearm

833

7140

1.03

0.30

1.5

1.4

132.83

134.50

pmol/l

0.04

805

6959

Cervical disc disorders

357

3436

1.04

0.30

1.5

1.4

145.40

157.35

pmol/l

0.14

348

3357

Anomalies of dental arch relationship, including avohilmo

187

1778

0.95

0.30

1.5

84.50

125.95

pmol/l

1.16

179

1728

Sequelae of injuries of upper limb

716

1.09

0.29

1.5

108.54

181.09

pmol/l

1.28

701

Acute laryngitis and tracheitis

104

951

1.08

0.29

1.6

1.4

63.52

119.36

pmol/l

1.85

927

Diseases of inner ear

579

5436

1.03

0.29

1.5

1.4

124.69

156.70

pmol/l

1.59

565

5301

Other abnormal products of conception

585

3987

0.97

0.29

1.4

67.25

90.88

pmol/l

1.37

572

3901

Other and unspecified nerve root and plexus disorders, also in other diseases

170

1796

0.95

0.29

1.4

1.5

64.89

148.00

pmol/l

7.91

165

1751

Atrial septal defect

258

1.16

0.29

1.4

84.32

126.14

pmol/l

0.45

252

Childhood asthma (age<16)

131

968

1.07

0.29

1.4

45.10

46.63

pmol/l

0.28

124

941

Injuries to the neck

210

1999

1.05

0.29

1.4

91.17

124.08

pmol/l

0.94

202

1943

Hyperprolactinaemia

387

0.88

0.29

1.4

47.95

113.14

pmol/l

1.42

380

Foreign body entering into or through eye or natural orifice

387

0.88

0.28

1.3

1.5

102.21

176.96

pmol/l

0.73

377

D07AA Corticosteroids, weak (group I)

152

1432

1.06

0.28

1.4

1.5

72.50

124.56

pmol/l

2.48

146

1399

Insulin, fast-acting

249

2601

0.96

0.28

1.4

144.50

143.24

pmol/l

0.02

240

2528

Non-small cell lung cancer, adenocarcinoma, helper endpoint

298

1.14

0.28

1.4

1.5

185.15

281.39

pmol/l

0.56

293

Fracture of rib(s), sternum and thoracic spine

188

1786

1.05

0.28

1.5

144.96

181.01

pmol/l

0.77

183

1735

Mental disorders, not otherwise specified

835

0.92

0.28

1.4

1.5

72.35

134.35

pmol/l

1.43

816

Cerebral cysts

441

1.11

0.28

1.4

1.5

69.90

143.76

pmol/l

1.25

430

Postprocedural disorders of nervous system

806

1.08

0.28

1.4

52.62

107.97

pmol/l

2.01

789

Chronic periodontitis, complicated

467

4774

0.97

0.27

1.4

151.24

153.81

pmol/l

0.05

457

4666

Thyrotoxicosis

324

3120

1.04

0.27

1.4

1.5

197.75

141.85

pmol/l

0.44

318

3033

Erysipelas

440

3767

1.03

0.27

1.5

1.4

179.90

143.33

pmol/l

0.56

428

3672

Arthropod-borne viral fevers and viral haemorrhagic fevers

575

1.10

0.27

1.4

1.5

107.36

184.10

pmol/l

1.12

565

Postpartum hemorraghe, all women as controls

448

4271

1.03

0.27

1.4

54.54

86.65

pmol/l

5.27

437

4167

Covid-19 suspected case

246

2355

1.05

0.27

1.4

112.71

111.90

pmol/l

0.01

241

2297

Autoimmune hyperthyroidism

768

1.08

0.27

1.4

1.5

195.91

139.47

pmol/l

0.20

754

Other disorders of electrolyte and fluid balance, not elsewhere classified

1.24

0.27

1.9

1.5

250.50

427.89

pmol/l

—

Substance abuse

409

3972

0.97

0.27

1.5

1.4

135.80

117.73

pmol/l

0.32

401

3868

Other disorders of ear

985

6587

0.98

0.27

1.4

116.80

141.73

pmol/l

1.51

956

6437

Graves ophthalmopathy

268

0.85

0.27

1.1

1.4

74.17

211.19

pmol/l

1.42

263

Disorders of lacrimal system and orbit in diseases classified elsewhere

268

0.85

0.27

1.1

1.4

74.17

213.49

pmol/l

1.45

262

Disorders of orbit

414

1.11

0.26

1.5

94.68

213.96

pmol/l

1.66

405

Other sexually transmitted chlamydial diseases

905

1.07

0.26

1.4

43.82

55.35

pmol/l

1.66

875

Aphakia

1.20

0.26

1.1

1.4

67.63

232.16

pmol/l

—

Other sexually transmitted chlamydial diseases

606

1.09

0.26

1.4

44.49

50.79

pmol/l

1.05

587

Fall on and from stairs and steps

241

2310

1.04

0.26

1.4

149.22

157.26

pmol/l

0.12

233

2245

Childhood allergy (age < 16)

113

992

0.94

0.26

1.3

1.4

45.38

46.16

pmol/l

0.08

107

940

Other disorders of adrenal gland

367

1.12

0.26

1.4

81.27

195.35

pmol/l

1.66

360

Bronchitis

1299

8033

1.02

0.25

1.5

1.4

127.90

125.14

pmol/l

0.06

1251

7841

Implicit Sepsis

727

5352

1.02

0.25

1.5

1.4

191.79

139.72

pmol/l

1.79

698

5222

Sleep apnoea

1025

6766

0.98

0.25

1.4

123.41

138.08

pmol/l

0.46

996

6616

Hyperlipidaemia, other/unspecified

280

2480

1.04

0.25

1.5

1.4

163.85

177.32

pmol/l

0.19

267

2429

Mental and behavioural disorders due to sedatives or hypnotics

477

0.90

0.25

1.6

1.5

159.10

176.96

pmol/l

0.07

471

Viral haemorrhagic fevers, not elsewhere classified/unspecified

116

1231

0.94

0.25

1.3

1.5

111.18

161.23

pmol/l

1.24

116

1202

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.28

0.24

1.4

170.86

64.04

pmol/l

—

Multiple myeloma

1.28

0.24

1.4

170.86

64.04

pmol/l

—

Retinal detachments and breaks

280

2699

1.04

0.24

1.4

1.5

133.65

176.44

pmol/l

1.07

274

2636

Acute and subacute iridocyclitis

173

1650

1.05

0.24

1.4

300.36

146.92

pmol/l

1.14

167

1609

Keratitis

327

3381

0.97

0.24

1.4

1.5

90.93

135.57

pmol/l

2.38

322

3287

Atopic dermatitis, strict definition with reimbursement

358

3567

0.97

0.23

1.4

69.64

104.80

pmol/l

2.69

348

3474

Abrasion of teeth

409

3971

1.03

0.23

1.5

1.4

83.44

133.20

pmol/l

5.09

397

3879

Asthma-related infections

629

6014

1.02

0.23

1.5

1.4

154.32

130.73

pmol/l

0.48

611

5853

Asthma, hospital admission 2, infections

629

6014

1.02

0.23

1.5

1.4

154.32

130.73

pmol/l

0.48

611

5853

Intentional self-harm by sharp object

190

0.84

0.23

1.3

55.69

65.21

pmol/l

0.44

182

Meniscus derangement

551

3807

0.97

0.23

1.4

163.63

142.08

pmol/l

0.32

534

3720

Contact with machinery

218

1.15

0.23

1.5

1.4

74.04

217.83

pmol/l

1.15

213

Heart failure,strict

365

2495

1.03

0.23

1.5

1.4

248.08

183.34

pmol/l

1.06

356

2433

Diabetes medication

1245

7504

0.98

0.23

1.4

167.97

117.60

pmol/l

1.80

1203

7332

Unknown and unspecified causes of morbidity

567

0.92

0.23

1.4

106.90

190.01

pmol/l

1.20

554

Psoriasis vulgaris

134

1411

0.95

0.23

1.5

132.03

167.14

pmol/l

0.37

129

1376

Nonsuppurative otitis media

211

1752

1.04

0.22

1.6

1.5

77.98

116.43

pmol/l

1.66

200

1699

Implicit Sepsis

839

6009

1.02

0.22

1.5

1.4

178.88

131.94

pmol/l

1.88

810

5861

Other disorders of amniotic fluid and membranes

219

2223

0.96

0.22

1.5

1.4

69.86

79.80

pmol/l

0.27

212

2168

Malignant neoplasm of adrenal gland, including Hilmo

1.25

0.22

1.0

1.3

60.60

52.80

pmol/l

—

Cholesteatoma of external ear

1.25

0.22

1.2

1.4

74.00

90.56

pmol/l

—

Polyarthritis, unspecified

276

1.13

0.22

1.6

1.5

210.06

207.85

pmol/l

0.01

271

Sacroiliitis, not elsewhere classified

458

1.09

0.22

1.6

1.5

72.44

120.83

pmol/l

0.94

449

Finngen Rheumatological endpoints

1156

6685

0.98

0.22

1.4

126.18

113.81

pmol/l

0.35

1126

6521

Erythema ab igne [dermatitis ab igne]

0.00

0.22

0.0

1.4

—

73.80

—

Edwards' syndrome and Patau's syndrome

0.00

0.22

0.0

1.5

—

54.64

—

Pemphigus foliaceus

0.00

0.22

0.0

1.2

—

81.45

—

Anxious personality disorder

167

0.84

0.21

1.3

1.4

143.50

157.65

pmol/l

0.04

162

Squamous cell neoplasms and carcinoma of rectum

0.00

0.21

0.0

1.2

—

68.20

—

Colorectal squamous cell carcinoma

0.00

0.21

0.0

1.2

—

68.20

—

Profound mental retardation

0.00

0.21

0.0

1.5

—

49.56

—

Fusion of the labia

0.00

0.21

0.0

1.0

—

52.50

—

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

0.00

0.21

0.0

1.2

—

60.30

—

Hypotony of eye

0.00

0.21

0.0

1.1

—

987.36

—

Symptoms and signs involving the nervous and musculoskeletal systems

607

5932

1.02

0.21

1.4

101.09

141.65

pmol/l

2.80

583

5792

Other salmonella infections

267

1.13

0.21

1.4

174.70

239.44

pmol/l

0.31

261

Epidermolysis bullosa

0.00

0.21

0.0

1.4

—

51.78

—

Postinflammatory hyperpigmentation

0.00

0.21

0.0

1.2

—

71.00

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.21

0.0

1.2

—

53.60

—

Nonadministration of surgical and medical care

0.00

0.21

0.0

1.3

—

57.82

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.5

—

49.26

—

Calcinosis cutis

0.00

0.21

0.0

1.2

—

72.50

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.4

—

49.50

—

Other retinal disorders in diseases classified elsewhere

0.00

0.21

0.0

1.5

—

47.34

—

Traumatic amputation of ankle and foot

0.00

0.21

0.0

1.3

—

59.94

—

Short stature starting before birth

0.00

0.21

0.0

1.6

—

41.18

—

Yaws

0.00

0.21

0.0

1.7

—

47.42

—

Alcohol use disorder, ICD-based

226

2346

0.96

0.21

1.4

1.5

151.41

128.26

pmol/l

0.24

221

2284

Ebstein's anomaly

0.00

0.21

0.0

1.3

—

51.58

—

Pneumoconiosis due to asbestos and other mineral fibres

0.00

0.21

0.0

1.3

—

96.36

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.21

0.0

1.3

—

65.05

—

Maternal care for known or suspected abnormality of pelvic organs

442

3089

0.97

0.21

1.4

68.45

90.07

pmol/l

1.24

428

3018

Erythrasma

0.00

0.21

0.0

1.2

—

64.22

—

Pediculosis and phthiriasis

0.00

0.21

0.0

1.3

—

68.92

—

Diseases of middle ear and mastoid

641

5129

1.02

0.21

1.5

1.4

98.72

114.11

pmol/l

0.53

609

4991

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.21

0.0

1.4

—

46.67

—

Ulcerative proctitis

502

0.91

0.21

1.3

1.5

70.94

138.05

pmol/l

1.03

491

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.16

0.21

2.2

1.3

95.00

60.06

pmol/l

—

Chronic lower respiratory diseases

1461

7666

1.01

0.21

1.5

1.4

137.53

120.82

pmol/l

0.47

1428

7463

Dengue fever [classical dengue]

0.00

0.21

0.0

1.5

—

49.89

—

Exposure to uncontrolled fire, not in building or structure

0.00

0.21

0.0

1.5

—

61.69

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.3

—

75.49

—

Congenital malformations of larynx

0.00

0.21

0.0

1.3

—

70.28

—

Trigger finger

148

1549

0.95

0.21

1.4

88.09

145.59

pmol/l

3.49

143

1511

Burns and corrosions

873

0.94

0.20

1.5

67.81

144.97

pmol/l

2.65

854

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.20

0.0

1.2

—

797.10

—

Hereditary lymphedema

0.00

0.20

0.0

1.4

—

62.79

—

Infections of genitourinary tract in pregnancy

148

1415

1.05

0.20

1.5

121.31

142.36

pmol/l

0.18

142

1384

Assault by drugs, medicaments and biological substances

0.00

0.20

0.0

1.4

—

56.76

—

Disorders of glossopharyngeal nerve

0.00

0.20

0.0

1.1

—

79.26

—

Relapsing fevers

0.00

0.20

0.0

1.1

—

68.93

—

Melanoma in situ of scalp and neck

0.00

0.20

0.0

1.5

—

90.93

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.20

0.0

1.4

—

43.57

—

Personality disorders, excluding more controls

276

2849

0.97

0.20

1.5

110.97

104.47

pmol/l

0.08

269

2775

Other cataract

368

2863

0.97

0.20

1.5

162.98

172.19

pmol/l

0.11

353

2797

Artificial joint re-operation

521

0.92

0.20

1.5

87.33

263.37

pmol/l

4.07

508

Allergic rhinitis

356

3617

0.97

0.20

1.4

1.5

91.45

105.97

pmol/l

0.42

346

3525

Atopic dermatitis, strict definition

342

3444

0.97

0.20

1.4

1.5

69.55

98.97

pmol/l

1.94

333

3349

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

626

1.07

0.19

1.5

1.6

86.45

229.96

pmol/l

3.93

613

All-cause Heart Failure

373

2705

0.97

0.19

1.5

1.4

247.75

203.08

pmol/l

0.64

364

2633

Syncope and collapse

396

3302

1.03

0.19

1.4

157.44

142.04

pmol/l

0.25

381

3210

ILD, hospital admission 2, with pulmonary infections

510

0.92

0.19

1.7

1.5

199.64

251.79

pmol/l

0.31

492

Abnormal reflex

1.16

0.19

2.5

1.4

53.83

82.94

pmol/l

—

Injuries to the thorax

327

3177

1.03

0.19

1.5

1.4

123.86

162.28

pmol/l

1.57

314

3077

Other hammer toe(s) (acquired)

195

1866

0.96

0.19

1.4

1.5

108.00

189.42

pmol/l

5.14

189

1820

Disorders of vitreous body

513

4845

1.02

0.19

1.5

1.4

133.57

167.86

pmol/l

1.12

502

4726

Graves ophthalmopathy, strict

228

0.87

0.19

1.2

1.4

78.40

233.86

pmol/l

1.34

223

Diseases of arteries, arterioles and capillaries (FINNGEN)

182

1309

0.96

0.19

1.5

1.4

153.84

138.10

pmol/l

0.27

174

1286

Other and unspecified follicular disorders

259

0.89

0.18

1.4

64.96

140.17

pmol/l

0.94

251

Symptoms and signs involving cognition, perception, emotional state and behaviour

1101

7613

0.99

0.18

1.4

133.99

128.05

pmol/l

0.12

1076

7420

Congenital malformations of the nervous system

185

0.86

0.18

1.7

1.3

45.38

65.71

pmol/l

2.14

180

Acute sinusitis

635

5766

1.02

0.18

1.4

106.06

115.03

pmol/l

0.27

614

5630

Condition for Implicit Sepsis (Organ dysfunction codes)

997

6767

1.02

0.18

1.5

1.4

164.61

126.83

pmol/l

1.66

966

6602

Ganglion

255

2628

0.97

0.18

1.4

122.35

125.29

pmol/l

0.04

249

2559

Heart failure, strict

381

2754

0.98

0.18

1.5

244.79

201.93

pmol/l

0.62

372

2680

Other disorders of eyelid

444

4132

1.02

0.18

1.4

114.26

184.91

pmol/l

4.73

434

4022

Assault by sharp object

1.17

0.18

1.4

1.5

77.29

71.38

pmol/l

—

Conjunctivitis (acute, non atopic)

292

2829

1.03

0.17

1.5

1.4

101.89

131.51

pmol/l

0.82

286

2747

Other disorders of eye and adnexa

146

1402

1.04

0.17

1.4

94.12

150.56

pmol/l

1.67

139

1366

Other disorders of patella

210

2032

1.03

0.17

1.4

1.5

127.06

119.36

pmol/l

0.09

204

1977

291

2742

0.97

0.17

1.5

188.64

208.61

pmol/l

0.29

278

2670

Unspecified lump in breast

233

2259

1.03

0.17

1.4

1.5

148.09

161.61

pmol/l

0.15

228

2202

Papulosquamous disorders

368

3770

0.98

0.17

1.4

121.09

152.30

pmol/l

0.83

360

3670

Ehlers-Danlos syndrome

129

1.17

0.17

1.5

1.4

51.27

66.67

pmol/l

0.80

124

Primary coxarthrosis, bilateral

223

2161

1.03

0.17

1.3

1.5

154.67

218.62

pmol/l

1.52

215

2101

Falls/tendency to fall

1350

6844

0.99

0.17

1.4

113.26

121.12

pmol/l

0.25

1309

6685

Pedal cyclist injured in transport accident

190

1837

1.03

0.17

1.5

67.72

143.33

pmol/l

5.61

182

1791

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

277

0.90

0.16

1.2

1.5

56.68

99.35

pmol/l

0.56

269

Other external causes of accidental injury

1059

5377

0.99

0.16

1.4

113.74

129.51

pmol/l

0.48

1033

5261

Fracture of femur

171

1605

0.97

0.16

1.3

1.4

195.82

232.26

pmol/l

0.43

162

1560

Other neurotic disorders

339

0.91

0.16

1.4

1.5

114.58

213.87

pmol/l

0.90

332

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

235

0.89

0.16

1.4

61.71

122.19

pmol/l

0.70

230

Gestational diabetes (for exclusion)

660

4667

0.98

0.15

1.5

1.4

65.18

78.88

pmol/l

1.18

640

4557

Conotruncal defects

0.76

0.15

1.0

1.3

52.33

194.68

pmol/l

—

Thoracic aortic aneurysm

438

1.07

0.15

1.5

106.26

248.77

pmol/l

2.32

430

Hypermetropia

543

0.94

0.15

1.3

1.5

86.58

190.63

pmol/l

1.87

531

Chronic conjunctivitis

265

0.90

0.15

1.5

1.4

99.42

217.69

pmol/l

0.94

260

Anisometropia and aniseikonia

244

0.90

0.14

1.6

1.4

62.36

206.14

pmol/l

1.47

237

Other enthesopathies

360

3524

1.02

0.14

1.5

1.4

98.75

140.15

pmol/l

3.40

353

3444

Hyperkinetic disorders (excl. ADHD)

0.79

0.14

1.4

1.3

48.43

46.76

pmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

246

2512

0.97

0.14

1.4

162.21

126.80

pmol/l

0.41

240

2446

Dipeptidyl peptidase 4 (DPP-4) inhibitors

442

3606

0.98

0.14

1.5

1.4

218.42

158.44

pmol/l

1.02

427

3516

Benign neoplasm of mouth and pharynx

821

1.05

0.14

1.6

1.5

99.19

191.14

pmol/l

2.01

803

Disorders of lipoprotein metabolism and other lipidaemias

799

5017

0.99

0.14

1.5

1.4

198.62

140.53

pmol/l

1.91

769

4917

Amblyopia ex anopsia

285

0.91

0.14

1.4

64.27

197.47

pmol/l

1.49

276

Use of interferon beta-1a

264

0.91

0.14

1.5

1.4

69.20

104.10

pmol/l

0.39

258

Skin changes due to chronic exposure to nonionizing radiation

269

2541

0.98

0.14

1.6

1.5

190.37

216.57

pmol/l

0.38

258

2470

Disorders of ocular muscles, binocular movement, accommodation and refraction

513

5172

0.98

0.14

1.5

1.4

83.44

121.59

pmol/l

2.78

496

5033

Exposure to other and unspecified animate mechanical forces

264

0.91

0.14

1.5

1.4

56.88

104.74

pmol/l

0.63

257

Retinal detachment with retinal break

757

0.95

0.14

1.5

179.83

203.80

pmol/l

0.12

741

Other symptoms and signs involving the nervous and musculoskeletal systems

454

4457

1.02

0.14

1.4

77.05

136.02

pmol/l

9.53

435

4348

Acute and transient psychotic disorders

981

0.96

0.14

1.3

1.5

101.01

156.34

pmol/l

1.23

962

Varicella [chickenpox]

208

1.11

0.14

1.2

1.4

70.39

137.93

pmol/l

0.59

201

Degenerative macular diseases

822

1.05

0.14

1.3

1.4

176.72

212.96

pmol/l

0.52

795

Injury of nerves at wrist and hand level

218

1.10

0.13

1.2

1.3

107.92

142.92

pmol/l

0.19

212

Benign neoplasm: Skin of trunk

325

1.08

0.13

1.7

1.4

134.65

208.45

pmol/l

0.58

318

Other congenital malformations of ear

117

0.85

0.13

1.5

1.3

38.90

52.86

pmol/l

—

111

Spondylopathies

839

5075

0.99

0.13

1.4

139.91

141.40

pmol/l

0.02

819

4955

Superficial injury of lower leg

254

2482

1.02

0.13

1.4

1.5

207.40

138.55

pmol/l

0.51

241

2412

Other conjunctival vascular disorders and cysts

190

1.11

0.13

1.2

1.4

71.90

260.71

pmol/l

1.42

185

Persons with potential health hazards related to communicable diseases

440

4287

1.02

0.12

1.4

79.20

95.31

pmol/l

1.00

422

4174

Suggestive for eosinophilic asthma

648

1.05

0.12

1.6

1.5

84.75

180.51

pmol/l

2.35

638

Other protozoal intestinal diseases

127

0.86

0.12

1.2

1.4

44.09

192.95

pmol/l

0.92

121

Other renal tubulo-interstitial diseases

231

0.91

0.12

2.1

1.4

266.03

145.17

pmol/l

0.45

225

Other secondary coxarthrosis

231

0.91

0.12

1.5

1.6

192.05

256.18

pmol/l

0.19

226

Tuberculosis, IBD comorbidity

365

1.07

0.12

1.3

1.5

131.50

237.10

pmol/l

1.16

357

Other and unspecified injuries of wrist and hand

297

1.08

0.12

1.8

1.4

62.66

167.32

pmol/l

1.74

289

Excessive attrition of teeth

659

6503

1.01

0.12

1.4

88.45

118.32

pmol/l

2.34

637

6347

Neuralgia and neuritis, unspecified

457

0.94

0.12

1.6

1.5

73.53

160.34

pmol/l

2.17

449

Senile cataract

534

3320

0.98

0.12

1.3

1.5

166.89

169.18

pmol/l

0.03

517

3242

Condition for Implicit Sepsis (Organ dysfunction codes)

880

6277

0.99

0.11

1.5

1.4

177.33

130.18

pmol/l

2.01

850

6129

Tuberculosis, wide

376

1.06

0.11

1.3

1.5

129.69

255.78

pmol/l

1.46

367

Conductive and sensorineural hearing loss

774

5281

0.99

0.11

1.4

128.04

156.98

pmol/l

1.51

751

5153

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

602

1.05

0.11

1.6

1.4

61.96

91.79

pmol/l

0.78

585

Fracture of forearm

653

6053

0.99

0.11

1.5

1.4

141.69

145.64

pmol/l

0.08

630

5897

Cleft lip, lip and palate or palate

136

0.88

0.11

1.7

1.3

61.00

53.64

pmol/l

0.29

131

Injuries to the abdomen, lower back, lumbar spine and pelvis

330

3321

0.98

0.11

1.4

119.26

159.24

pmol/l

1.32

320

3223

Degeneration of macula and posterior pole

376

2943

1.02

0.10

1.4

1.5

209.83

200.91

pmol/l

0.09

356

2874

Viral conjunctivitis

202

1.09

0.10

1.2

1.4

100.18

190.19

pmol/l

0.51

197

Fracture of foot, except ankle

239

2342

1.02

0.10

1.4

1.5

111.72

129.33

pmol/l

0.45

233

2278

Persistent mood disorders

198

1936

1.02

0.10

1.3

1.4

119.05

147.29

pmol/l

0.42

191

1886

Valvular heart disease excluding rheumatic fever

383

2721

1.02

0.10

1.4

134.41

170.94

pmol/l

1.48

373

2653

Type 2 diabetes, definitions combined, including avohilmo

1172

6763

1.01

0.10

1.4

158.48

122.13

pmol/l

1.04

1135

6609

Aortic aneurysm

585

0.96

0.10

1.5

101.18

244.95

pmol/l

3.16

571

Tracheo-bronchomalasia

1.14

0.10

1.0

1.5

384.20

128.30

pmol/l

—

Impacted teeth

190

1653

1.02

0.10

1.4

53.28

70.21

pmol/l

1.03

182

1591

Spontaneous abortion

854

5701

1.01

0.09

1.4

130.81

121.20

pmol/l

0.20

834

5565

Crystalline deposits in vitreous body

1.09

0.09

1.8

1.6

54.14

314.24

pmol/l

—

Strabismus

261

2557

1.02

0.09

1.4

90.26

131.40

pmol/l

1.29

254

2486

Disorders of lens

613

3869

0.99

0.09

1.4

153.81

155.88

pmol/l

0.03

596

3779

Coxarthrosis [arthrosis of hip](FG)

505

3597

0.99

0.09

1.4

138.67

158.18

pmol/l

0.57

492

3515

Leisure time condition

139

1425

0.98

0.09

1.4

134.91

157.54

pmol/l

0.33

134

1383

Contact with and exposure to communicable diseases

361

3646

0.99

0.09

1.5

56.23

88.75

pmol/l

4.41

346

3548

Unspecified acute lower respiratory infection

909

0.97

0.09

1.5

1.4

117.64

156.14

pmol/l

0.38

888

Sensorineural hearing loss

720

4936

0.99

0.09

1.5

1.4

130.88

163.74

pmol/l

1.68

701

4814

Artificial joint operation, meniscal resection

896

5867

0.99

0.09

1.4

186.26

143.95

pmol/l

0.78

873

5726

Intracranial injury

540

5048

1.01

0.09

1.4

113.83

137.33

pmol/l

1.05

516

4911

Cleft palate

1.14

0.09

1.6

1.4

62.82

51.91

pmol/l

0.43

Malignant neoplasm of anus and anal canal, including Hilmo

1.11

0.09

1.0

1.4

54.67

66.40

pmol/l

—

Pregnancy with abortive outcome

1214

6381

0.99

0.09

1.5

1.4

147.26

129.59

pmol/l

0.47

1175

6216

Vitamin B12 deficiency anaemia

675

1.04

0.09

1.4

237.49

204.05

pmol/l

0.10

655

Hypertension, Pulmonary Arterial

1.07

0.08

2.2

1.4

168.17

161.86

pmol/l

—

Herpesviral keratitis and keratoconjunctivitis

308

0.94

0.08

1.1

1.4

108.49

195.75

pmol/l

0.87

303

Abnormalities of forces of labour

160

1634

0.98

0.08

1.3

1.4

110.13

92.86

pmol/l

0.20

155

1599

Diseases of the eye and adnexa

1003

4983

1.01

0.08

1.5

1.4

104.84

117.25

pmol/l

0.38

986

4859

Type 2 diabetes

1219

7069

1.01

0.08

1.5

1.4

164.61

119.36

pmol/l

1.52

1179

6904

Non-rheumatic valve diseases

381

2712

1.01

0.08

1.4

134.04

171.38

pmol/l

1.53

371

2644

Common variable immunodeficiency

0.82

0.08

1.4

1.6

83.00

70.06

pmol/l

—

Maternal care for known or suspected malpresentation of fetus

339

2422

1.01

0.08

1.4

51.68

64.31

pmol/l

2.09

331

2363

Complications of labour and delivery

1155

6375

1.01

0.08

1.4

100.18

127.37

pmol/l

1.79

1131

6209

Injuries to the hip and thigh

385

3442

1.01

0.08

1.4

1.5

138.23

174.71

pmol/l

1.05

366

3354

Non-selective monoamine reuptake inhibitors

416

4057

0.99

0.08

1.5

1.4

176.81

148.64

pmol/l

0.36

407

3969

Other assisted single delivery

293

1.06

0.08

1.6

1.5

52.71

63.49

pmol/l

0.82

286

Coxarthrosis, primary

506

4328

0.99

0.08

1.4

148.83

180.01

pmol/l

0.99

492

4219

Coxarthrosis

462

3084

0.99

0.07

1.4

138.30

158.56

pmol/l

0.54

454

3012

Other retinal artery occlusion

1.12

0.07

1.9

1.6

200.18

304.99

pmol/l

0.28

Embolic stroke with flimmer

0.82

0.07

1.7

1.5

103.50

358.05

pmol/l

—

Other maltreatment syndromes

176

1.08

0.07

1.4

68.26

126.21

pmol/l

0.46

171

Patent foramen ovale

143

0.91

0.07

1.3

1.4

41.48

146.56

pmol/l

0.80

138

Psoriasis (vulgaris), strict definition

184

0.92

0.07

1.5

1.4

120.71

159.19

pmol/l

0.24

179

Scabies

284

1.06

0.07

1.3

1.4

51.37

131.11

pmol/l

1.20

277

Atypical mycobacterium lung infection

0.86

0.07

1.7

1.5

113.57

232.94

pmol/l

—

Toxic effect of ethanol

245

1.06

0.07

1.3

1.4

61.54

146.10

pmol/l

1.03

238

Alopecia areata

265

0.94

0.07

1.2

1.5

61.32

201.55

pmol/l

1.49

260

Disorders of sclera, cornea, iris and ciliary body

563

5581

1.01

0.07

1.4

154.47

133.12

pmol/l

0.35

546

5443

Diabetes mellitus

1269

7373

1.01

0.07

1.4

160.93

116.30

pmol/l

1.58

1229

7200

Duodenal ulcer

462

1.04

0.07

1.6

1.5

350.00

225.67

pmol/l

0.50

451

Hallux valgus (acquired)

476

3390

1.01

0.06

1.4

143.10

148.97

pmol/l

0.12

459

3312

Dermatophytosis

588

5825

1.01

0.06

1.4

106.74

130.93

pmol/l

0.92

575

5681

Preterm labour and delivery

419

4230

0.99

0.06

1.5

1.4

89.73

124.62

pmol/l

2.50

407

4136

Open wound of lower leg

113

1106

1.02

0.06

1.7

1.5

118.12

161.44

pmol/l

0.64

108

1073

142

0.91

0.06

1.5

1.4

45.31

51.16

pmol/l

0.23

137

Papilloedema, unspecified

193

0.93

0.06

1.7

1.4

170.06

122.81

pmol/l

0.15

188

Bipolar affective disorders

195

1979

0.99

0.06

1.3

1.5

90.19

112.72

pmol/l

0.70

187

1935

Disorders of refraction and accommodation

276

2782

0.99

0.06

1.5

76.06

121.22

pmol/l

3.90

265

2707

Blepharochalasis

299

3023

0.99

0.06

1.4

113.61

195.15

pmol/l

3.73

292

2947

Chromosomal abnormalities, not elsewhere classified

148

1.08

0.06

1.3

57.50

58.57

pmol/l

0.03

143

Idiopathic pulmonary fibrosis

294

0.95

0.06

2.4

1.5

152.61

303.73

pmol/l

1.57

288

Conduction disorders

203

1668

0.99

0.05

1.5

1.4

213.89

199.42

pmol/l

0.11

198

1625

Placental disorders

131

0.91

0.05

1.1

1.3

46.50

151.53

pmol/l

0.70

126

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

194

1702

1.01

0.05

1.4

53.21

65.69

pmol/l

0.63

188

1640

Other salmonella infections

326

1.04

0.05

1.4

1.5

175.71

210.15

pmol/l

0.17

319

Hereditary corneal dystrophies

267

1.05

0.05

1.1

1.5

73.19

233.22

pmol/l

2.37

262

Open wound of forearm

574

1.03

0.05

1.4

1.5

119.39

173.56

pmol/l

0.68

556

Biguanides

1113

6814

1.00

0.05

1.4

152.19

126.30

pmol/l

1.33

1077

6661

Transport accidents

523

4529

0.99

0.05

1.5

1.4

81.56

126.79

pmol/l

3.72

499

4429

Actinic keratosis

260

2431

0.99

0.05

1.6

1.5

193.74

222.51

pmol/l

0.41

250

2367

Complications predominantly related to the puerperium

431

4341

0.99

0.04

1.4

1.5

68.69

112.89

pmol/l

6.75

421

4239

Anomalies of pupillary function

199

1.06

0.04

1.6

1.3

96.43

160.47

pmol/l

0.40

194

Thyrotoxicosis with toxic multinodular goitre

605

1.03

0.04

1.4

1.5

133.61

234.72

pmol/l

1.28

589

Other bursopathies

110

1082

1.02

0.04

1.5

1.4

120.54

166.50

pmol/l

0.83

110

1058

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

298

1.04

0.04

1.5

1.4

70.49

120.97

pmol/l

0.62

287

Type 2 diabetes, strict (exclude DM1)

1158

6769

1.00

0.04

1.5

1.4

168.55

122.99

pmol/l

1.41

1123

6614

Polypectomy (DHB20)

298

1.04

0.04

1.3

1.4

77.42

202.43

pmol/l

1.48

293

Pure hypercholesterolaemia

692

4491

1.01

0.04

1.5

1.4

219.85

145.75

pmol/l

2.31

665

4399

Dislocation, sprain and strain of joint and ligaments of hip

231

0.95

0.04

1.2

1.5

92.39

280.10

pmol/l

1.68

225

Dizziness and giddiness

844

6718

1.00

0.04

1.4

139.14

135.47

pmol/l

0.06

823

6557

Obstructed labour due to maternal pelvic abnormality

235

2328

1.01

0.04

1.4

102.94

140.68

pmol/l

1.26

227

2274

Congenital malformations of great arteries

107

0.92

0.04

1.2

1.3

104.50

69.65

pmol/l

—

102

Tobacco use

378

1.03

0.04

1.6

1.4

168.16

156.61

pmol/l

0.06

370

Tuberculosis

281

0.96

0.04

1.3

1.5

129.37

284.54

pmol/l

1.51

276

Pollen allergy

200

1994

0.99

0.04

1.4

66.82

104.04

pmol/l

1.66

194

1941

Postpartum haemorrhage

448

3748

1.01

0.03

1.4

54.54

90.83

pmol/l

5.77

437

3660

Congenital malformations of cardiac septa

443

1.03

0.03

1.4

1.5

92.35

163.29

pmol/l

0.90

430

Type 2 diabetes, definitions combined

1153

6745

1.00

0.03

1.4

169.05

122.49

pmol/l

1.45

1118

6590

Cerebrovascular diseases (FINNGEN)

322

2262

1.01

0.03

1.5

1.4

135.19

109.91

pmol/l

0.47

315

2214

Primary open-angle glaucoma

240

2301

1.01

0.03

1.4

1.5

202.28

212.80

pmol/l

0.11

229

2238

Accidents

1070

5377

1.00

0.03

1.4

111.99

129.51

pmol/l

0.56

1044

5261

Hypertensive heart and/or renal disease

154

1137

1.01

0.03

1.4

1.5

470.57

196.36

pmol/l

1.69

147

1114

Vasomotor and allergic rhinitis

448

4419

0.99

0.03

1.5

1.4

115.19

117.57

pmol/l

0.04

434

4304

Synovial cyst of popliteal space [Baker]

642

0.98

0.03

1.4

1.5

110.22

179.89

pmol/l

1.56

629

Vitreous haemorrhage

638

1.02

0.03

1.4

1.5

147.63

213.91

pmol/l

0.81

624

Type 2 diabetes, wide definition

808

5152

1.00

0.03

1.5

1.4

208.58

135.47

pmol/l

3.04

779

5040

Other demyelinating diseases of the central nervous system

390

0.97

0.02

1.2

1.5

58.33

112.47

pmol/l

1.04

384

Maternal care for other known or suspected fetal problems

427

2716

1.00

0.02

1.4

66.70

65.46

pmol/l

0.05

415

2650

Fracture of lower leg, including ankle

581

5728

1.00

0.02

1.4

128.40

142.50

pmol/l

0.48

558

5599

Other strabismus

219

2197

0.99

0.02

1.5

1.4

91.44

128.25

pmol/l

0.86

212

2138

Allergic colitis

132

1.06

0.02

1.4

46.65

134.71

pmol/l

0.56

127

Congenital deformities of feet

321

1.03

0.02

1.3

1.4

68.88

129.04

pmol/l

0.89

314

Abnormal findings on antenatal screening of mother

125

1238

1.01

0.02

1.3

1.4

45.65

57.79

pmol/l

1.97

120

1201

Unspecified privation

800

1.01

0.02

1.3

1.5

142.21

170.57

pmol/l

0.26

785

Juvenile osteochondrosis

252

1.03

0.02

1.4

60.42

128.80

pmol/l

0.79

244

Autoimmune diseases excluding thyroid diseases, strict definition

1127

6183

1.00

0.02

1.4

160.15

115.21

pmol/l

1.43

1096

6023

Other extrapyramidal and movement disorders in other diseases

210

2089

1.01

0.01

1.3

1.4

88.99

184.64

pmol/l

6.71

204

2030

Congenital deformities of feet

213

1.03

0.01

1.2

1.4

78.09

144.06

pmol/l

0.59

208

Other and unspecified disorders of vitreous body

439

4317

1.00

0.01

1.5

1.4

137.26

171.57

pmol/l

0.94

433

4213

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

353

3477

1.00

0.01

1.4

81.61

93.73

pmol/l

0.32

344

3385

Soft tissue disorders related to use, overuse and pressure

273

2740

1.00

0.01

1.5

1.4

93.29

155.01

pmol/l

4.28

266

2669

Deviated nasal septum

197

1977

1.00

0.01

1.4

121.02

149.54

pmol/l

0.39

189

1931

Algoneurodystrophy

343

1.02

0.01

1.7

1.5

102.68

175.76

pmol/l

0.76

337

Embedded and impacted teeth

268

2219

1.00

0.01

1.5

1.4

53.96

84.20

pmol/l

2.36

258

2146

Injuries to the ankle and foot

813

7234

1.00

0.01

1.5

1.4

110.76

114.62

pmol/l

0.11

786

7054

Haemangioma, any site

777

0.99

0.01

1.4

1.5

61.12

175.39

pmol/l

4.09

763

Caries in Clefts patients

1.07

0.01

1.8

1.3

63.90

52.24

pmol/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

224

1.03

0.00

1.4

1.3

50.57

113.89

pmol/l

0.74

217

Fracture of shoulder and upper arm

318

3169

1.00

0.00

1.5

157.24

170.66

pmol/l

0.18

309

3078

Other/unspecified enthesopathies, not elsewhere classified

724

1.01

0.00

1.5

146.45

159.22

pmol/l

0.15

709

Other (not insulin) diabetes medications

1167

6926

1.00

0.00

1.4

168.61

123.97

pmol/l

1.38

1129

6771

Haemangioma and lymphangioma, any site

824

1.01

0.00

1.3

1.5

60.72

175.46

pmol/l

4.36

808

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

225

0.97

0.00

1.6

1.4

56.47

107.71

pmol/l

0.55

219

Pediculosis, acariasis and other infestations

348

1.01

0.00

1.4

51.09

168.55

pmol/l

1.76

339

Chronic viral hepatitis

321

1.00

0.00

1.4

81.28

109.78

pmol/l

0.36

314

Diabetes, varying definitions

1254

7353

1.00

0.00

1.4

162.10

116.56

pmol/l

1.60

1214

7181

Congenital malformations of the musculoskeletal system, not elsewhere classified

175

1.03

0.00

1.4

50.00

127.15

pmol/l

0.69

169

Gender identity disorders

1.02

0.00

1.1

1.3

48.00

42.60

pmol/l

—

Otitis media, unspecified

814

1.00

0.00

1.4

57.83

128.68

pmol/l

2.23

791

Perioral dermatitis

248

1.01

0.00

1.5

1.4

58.27

189.44

pmol/l

1.26

243

Other/unspecified synovitis and tenosynovitis

115

1154

1.00

0.00

1.5

1.4

118.69

153.94

pmol/l

0.57

109

1127

ILD medications: immunosuppressive drugs

721

6700

1.00

0.00

1.5

1.4

138.62

124.12

pmol/l

0.30

699

6534

Spinal stenosis

437

3313

1.00

0.00

1.4

181.58

175.38

pmol/l

0.06

422

3227

Disorders of optic nerve and visual pathways

889

1.00

0.00

1.6

1.5

136.83

159.74

pmol/l

0.22

870

Autoimmune diseases excluding thyroid diseases

1169

6380

1.00

0.00

1.4

157.13

115.02

pmol/l

1.37

1137

6216

Primary open-angle glaucoma, strict

195

1950

1.00

0.00

1.5

230.21

217.77

pmol/l

0.11

185

1894

Septal defects

426

1.01

0.00

1.5

93.60

168.25

pmol/l

0.91

414

Motorcycle rider injured in noncollision transport accidents

127

1.02

0.00

1.0

1.3

143.69

149.34

pmol/l

0.02

121

Mild mental retardation

161

0.99

0.00

1.4

88.56

135.18

pmol/l

0.30

156

Macular pucker, drug-induced

0.00

0.0

1.2

—

109.00

—

Common variable immunodeficiency with autoantibodies to B- or T-cells

0.00

0.0

1.2

—

70.80

—

Fracture of upper limb, level unspecified

0.00

0.0

1.0

—

76.80

—

Degeneration of iris and ciliary body

0.00

0.0

1.6

—

48.52

—

Compression of brain

0.00

0.0

1.3

—

61.43

—

Autoimmune polyglandular failure

0.00

0.0

1.4

—

35.37

—

Taeniasis

0.00

0.0

1.2

—

93.17

—

Drowning and submersion, undetermined intent

0.00

0.0

1.2

—

67.40

—

Use of apomorphine

0.00

0.0

1.3

—

70.83

—

Polyglandular dysfunction, other/unspecified

0.00

0.0

1.4

—

46.80

—

Inhalation of gastric contents

0.00

0.0

1.3

—

88.22

—

Crushing injury of head

0.00

0.0

1.3

—

77.17

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.0

1.3

—

50.34

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.1

—

54.13

—

Other disorders of bone development and growth

0.00

0.0

1.2

—

51.00

—

Use of pergolide

0.00

0.0

1.0

—

86.17

—

Vibratory urticaria

0.00

0.0

1.4

—

68.07

—

Myiasis

0.00

0.0

1.3

—

69.43

—

Nocardiosis

0.00

0.0

1.2

—

67.68

—

Accident to watercraft causing other injury

0.00

0.0

1.1

—

66.13

—

Polydactyly

0.00

-0.00

0.0

1.4

—

64.00

—

Pseudosarcomatous fibromatosis

0.00

-0.00

0.0

1.3

—

77.88

—

0.97

-0.00

2.1

1.3

45.57

40.48

pmol/l

—

Granuloma faciale [eosinophilic granuloma of skin]

0.00

-0.00

0.0

1.2

—

65.40

—

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.2

—

50.80

—

Classical phenylketonuria

0.00

-0.00

0.0

1.6

—

70.51

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

79.20

—

Malnutrition in pregnancy

0.00

-0.00

0.0

1.4

—

42.14

—

Alport

0.00

-0.00

0.0

1.4

—

51.25

—

Hereditary factor IX deficiency

0.00

-0.00

0.0

1.5

—

70.50

—

Non-small cell lung cancer, squamous

0.98

-0.00

1.0

1.4

114.12

68.36

pmol/l

—

Choroidal degeneration

0.00

-0.00

0.0

1.6

—

97.60

—

Traumatic secondary and recurrent haemorrhage

0.00

-0.00

0.0

1.3

—

78.00

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.4

—

88.60

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.3

—

79.23

—

Brain mixed glioma

0.00

-0.00

0.0

1.4

—

44.80

—

Café au lait spots

0.00

-0.00

0.0

1.9

—

51.00

—

Other migraine, drug-induced

0.00

-0.00

0.0

1.4

—

62.40

—

Hydroxyapatite deposition disease

0.00

-0.00

0.0

1.2

—

64.22

—

Myxoedema coma

0.00

-0.00

0.0

1.4

—

70.40

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.3

—

38.29

—

Coccidioidomycosis

0.00

-0.00

0.0

2.2

—

93.40

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.3

—

58.78

—

Night blindness

0.00

-0.00

0.0

1.2

—

44.80

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.0

—

51.50

—

Disorders of aromatic amino-acid metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

45.17

—

Noonan syndrome

0.00

-0.00

0.0

1.3

—

41.45

—

Need for immunization against combinations of infectious diseases

0.00

-0.00

0.0

1.3

—

46.93

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

-0.00

0.0

1.3

—

56.43

—

Anencephaly and similar malformations

0.00

-0.00

0.0

1.3

—

48.33

—

Osteolysis

0.00

-0.00

0.0

1.0

—

78.33

—

Other deformity of hallux (acquired)

0.88

-0.00

2.0

1.3

72.00

381.40

pmol/l

—

Other chronic figurate erythema

0.00

-0.00

0.0

1.0

—

66.40

—

Disorders of fatty-acid metabolism

0.00

-0.00

0.0

1.2

—

57.78

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.5

—

144.13

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.2

—

59.00

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

-0.00

0.0

1.1

—

56.91

—

Malignant neoplasm of nasopharynx

0.00

-0.00

0.0

1.0

—

64.83

—

Disorders of puberty, all

0.92

-0.00

1.4

1.3

34.56

44.76

pmol/l

—

Other accidental hanging and strangulation

0.00

-0.00

0.0

1.3

—

76.00

—

Palsy of conjugate gaze

0.00

-0.00

0.0

1.6

—

54.43

—

Disorders of puberty

0.98

-0.00

1.5

1.3

33.38

44.29

pmol/l

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.3

—

49.89

—

Sequelae of complication of pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.9

—

44.75

—

Bartonellosis

0.00

-0.00

0.0

1.2

—

77.00

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

1.3

—

72.50

—

Gastroenterology and urology devices associated with adverse incidents

0.00

-0.00

0.0

1.4

—

87.80

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

50.80

—

Other chorioretinal disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.5

—

46.63

—

Haemoglobinuria due to haemolysis from other external causes

0.00

-0.00

0.0

1.2

—

70.80

—

Discharge of firework

0.00

-0.00

0.0

1.8

—

44.67

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.1

—

46.88

—

Other porphyria

0.00

-0.00

0.0

1.3

—

67.63

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.4

—

45.14

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

-0.00

0.0

1.2

—

42.00

—

Echinococcosis

0.00

-0.00

0.0

1.2

—

71.80

—

Other transepidermal elimination disorders

0.00

-0.00

0.0

1.2

—

67.40

—

Underdevelopment of the second kidney

0.00

-0.00

0.0

1.2

—

91.40

—

Abscess of mediastinum

0.00

-0.00

0.0

1.6

—

80.44

—

Hyperimmunoglobulin E [IgE] syndrome

0.00

-0.00

0.0

1.4

—

58.00

—

Polyp of middle ear

0.00

-0.00

0.0

1.6

—

88.60

—

Congenital glaucoma

0.00

-0.00

0.0

1.4

—

77.70

—

Cardiomyopathy, Hypertrophic obstructive

0.93

-0.00

1.4

103.11

305.92

pmol/l

—

Other rickettsioses

0.00

-0.00

0.0

1.3

—

78.17

—

Otitis media in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

61.95

—

Hyperalimentation, other specified

0.00

-0.00

0.0

1.2

—

81.33

—

Other conditions originating in the perinatal period

0.00

-0.00

0.0

1.3

—

44.29

—

Vertiginous syndromes in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

90.07

—

Mental and behavioural disorders due to cocaine

0.00

-0.00

0.0

1.6

—

46.40

—

Erysipeloid

0.00

-0.00

0.0

1.1

—

77.33

—

Autonomic dysreflexia

0.00

-0.00

0.0

1.2

—

72.20

—

Fusion of the labia

0.00

-0.00

0.0

1.0

—

50.00

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.3

—

72.73

—

Neuropathy in association with hereditary ataxia

0.00

-0.00

0.0

1.2

—

108.60

—

Chromomycosis and phaeomycotic abscess

0.00

-0.00

0.0

1.4

—

66.00

—

Other congenital malformations, not elsewhere classified

0.89

-0.00

1.3

55.33

63.01

pmol/l

—

Interstitial myositis

0.00

-0.00

0.0

1.3

—

90.17

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

-0.00

0.0

1.2

—

47.00

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

50.33

—

Unspecified hairloss

0.00

-0.00

0.0

1.6

—

77.60

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.6

—

57.51

—

Disorders of purine and pyrimidine metabolism, other/unspecified

0.00

-0.00

0.0

1.4

—

55.12

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.0

—

62.40

—

Bacterial meningoencephalitis and meningomyelitis

0.00

-0.00

0.0

1.2

—

59.78

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

1.4

—

44.37

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.4

—

77.11

—

Asphyxiation

0.00

-0.00

0.0

1.2

—

51.50

—

Miliaria rubra

0.00

-0.00

0.0

1.4

—

50.20

—

Amputation of ankle

0.00

-0.00

0.0

1.0

—

79.67

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.2

—

52.89

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Human epididymis protein 4 [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS